Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
neuron: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
Type · 17,835 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bipolar disorder | PSYCH000023 | 153.93 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 2 | Reaction time | PSYCH000010 | 151.43 | Psychiatric | Neural / glial | 67 | 3 | 6 | 11 | |
| 3 | Worry | PSYCH000032 | 141.70 | Psychiatric | Neural / glial | 94 | 2 | 3 | 5 | |
| 4 | Professional qualification | SOCIO000003 | 131.32 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 5 | Water consumption | DTSUP000004 | 130.75 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 6 | Processing speed | PSYCH000008 | 124.11 | Psychiatric | Neural / glial | 65 | 4 | 10 | 18 | |
| 7 | Educational attainment, none | SOCIO000001 | 122.92 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 8 | Neuroticism | PSYCH000034 | 116.78 | Psychiatric | Neural / glial | 77 | 3 | 6 | 12 | |
| 9 | Reproductive timing | BEHAV000011 | 112.88 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 10 | Frailty, limited social support | SOCIO000017 | 111.41 | Socioeconomic | Neural / glial | 0 | 4 | 4 | 9 | |
| 11 | Adjustment disorder | PSYCH000051 | 111.14 | Psychiatric | Neural / glial | 0 | 5 | 6 | 16 | |
| 12 | Residential stability | SOCIO000014 | 109.43 | Socioeconomic | Neural / glial | 3 | 4 | 7 | 9 | |
| 13 | Medical condition | MISCL000028 | 106.11 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 14 | Sleep behaviour | BEHAV000016 | 105.11 | Behavioural | Neural / glial | 57 | 4 | 8 | 7 | |
| 15 | Fat mass | BCOMP000005 | 100.47 | Body composition | Neural / glial | 607 | 3 | 8 | 21 | |
| 16 | Household size | SOCIO000011 | 100.34 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 17 | Falling risk | MISCL000040 | 96.99 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 18 | Daytime napping | BEHAV000015 | 96.64 | Behavioural | Neural / glial | 81 | 5 | 11 | 25 | |
| 19 | Medication, hypnotic or sedative | PSYCH000020 | 95.47 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 20 | Cognitive function | PSYCH000002 | 92.69 | Psychiatric | Neural / glial | 282 | 3 | 5 | 17 | |
| 21 | Seafood preference | DTSUP000016 | 89.90 | Diet and Supplement | Neural / glial | 76 | 3 | 5 | 10 | |
| 22 | Food preparation preference | DTSUP000021 | 88.66 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 23 | Intelligence | PSYCH000004 | 87.12 | Psychiatric | Neural / glial | 305 | 2 | 3 | 13 | |
| 24 | Arm fat percentage | BCOMP000012 | 86.71 | Body composition | Neural / glial | 328 | 4 | 7 | 13 | |
| 25 | Autoimmune hepatitis | IMMUN000024 | 85.39 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 26 | Dietary preference | DTSUP000008 | 84.96 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 27 | Mood symptoms | PSYCH000029 | 82.41 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 28 | Occupational physical activity | BEHAV000006 | 81.38 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 29 | Electronic device use | BEHAV000017 | 80.57 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 30 | Social activity, none | SOCIO000018 | 80.12 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 31 | Memory function | PSYCH000007 | 78.66 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 32 | Body mass index, BMI | BMORP000002 | 77.93 | Body morphology | Neural / glial | 1,808 | 5 | 9 | 17 | |
| 33 | Dietary change, none | DTSUP000005 | 76.91 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 34 | Negative affect | PSYCH000030 | 76.14 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 35 | Abdominal and pelvic pain | GASTR000043 | 75.45 | Gastrointestinal | Neural / glial | 0 | 4 | 7 | 13 | |
| 36 | Body size, childhood | BMORP000004 | 74.28 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 37 | Educational attainment | SOCIO000002 | 74.06 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 38 | Social support | SOCIO000022 | 72.88 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 39 | Viral hepatitis | IMMUN000076 | 72.59 | Immunologic | Neural / glial | 3 | 4 | 10 | 17 | |
| 40 | Drink temperature | DTSUP000003 | 72.18 | Diet and Supplement | Neural / glial | 42 | 3 | 5 | 9 | |
| 41 | Meat preference | DTSUP000015 | 71.52 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 42 | Frailty, poorer cognition | PSYCH000001 | 70.86 | Psychiatric | Neural / glial | 40 | 2 | 7 | 9 | |
| 43 | Creativity | PSYCH000003 | 70.66 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 44 | Mood disorder, none | PSYCH000021 | 69.32 | Psychiatric | Neural / glial | — | 2 | 8 | 13 | |
| 45 | Loneliness | PSYCH000055 | 67.68 | Psychiatric | Neural / glial | 1 | 2 | 10 | 17 | |
| 46 | Waist circumference | BMORP000013 | 66.84 | Body morphology | Neural / glial | 286 | 5 | 8 | 19 | |
| 47 | Depression or anxiety | PSYCH000025 | 65.30 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 48 | Flavour preference | DTSUP000022 | 65.17 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 49 | Sexual behaviour | BEHAV000012 | 64.66 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 50 | Sedentary behaviour | BEHAV000008 | 64.22 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 51 | Supplement use, glucosamine | DTSUP000025 | 63.46 | Diet and Supplement | Neural / glial | 0 | 2 | 7 | 19 | |
| 52 | Commuting transport | SOCIO000004 | 63.21 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 53 | Sun exposure | BEHAV000001 | 62.11 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 54 | CFHR1 levels | PROLV000414 | 60.96 | Protein levels | Neural / glial | 6 | 2 | 6 | 10 | |
| 55 | Coffee preference | DTSUP000002 | 60.73 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 56 | Frailty, disability | MISCL000038 | 60.31 | Miscellaneous | Neural / glial | 3 | 3 | 10 | 4 | |
| 57 | Fruit preference | DTSUP000012 | 60.10 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 58 | Alcohol use | PSYCH000043 | 58.55 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 59 | Household composition | SOCIO000010 | 58.17 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 60 | Leg fat percentage | BCOMP000015 | 57.89 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 61 | Severe mental illness | PSYCH000017 | 57.83 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 62 | Trunk fat percentage | BCOMP000018 | 57.23 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 63 | Female genital inflammation | REPRO000008 | 56.67 | Reproductive | Neural / glial | 0 | 2 | 4 | 4 | |
| 64 | Movement disorder | NEURO000015 | 56.53 | Neurologic | Neural / glial | 43 | 2 | 7 | 11 | |
| 65 | Chronic illness or disability | MISCL000004 | 56.28 | Miscellaneous | Neural / glial | 10 | 5 | 14 | 24 | |
| 66 | Pregnancy complication, abortive | REPRO000027 | 56.26 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 67 | Obesity | METBL000008 | 54.82 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 68 | Psychiatric care | PSYCH000015 | 54.75 | Psychiatric | Neural / glial | 9 | 3 | 11 | 16 | |
| 69 | Weight | BMORP000015 | 54.71 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 70 | Snack and fast-food preference | DTSUP000017 | 54.27 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 71 | Schizophrenia | PSYCH000036 | 53.87 | Psychiatric | Neural / glial | 9 | 5 | 12 | 23 | |
| 72 | Circadian timing | BEHAV000014 | 53.09 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 73 | Body fat percentage | BCOMP000004 | 52.41 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 74 | Vegetable preference | DTSUP000020 | 52.24 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 75 | Cereal preference | DTSUP000010 | 52.23 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 76 | Multiple system atrophy | NEURO000020 | 52.02 | Neurologic | Neural / glial | 0 | 3 | 6 | 16 | |
| 77 | Cannabis use | PSYCH000045 | 51.33 | Psychiatric | Neural / glial | 9 | 5 | 11 | 26 | |
| 78 | Dyspnoea | RESPI000028 | 51.21 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 79 | Vaccination | IMMUN000085 | 50.96 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 80 | Social activity | SOCIO000020 | 50.72 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 81 | Disability allowance, none | SOCIO000016 | 49.84 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 82 | Non-cancer illness burden | MISCL000029 | 49.60 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 83 | Consultant specialty, anaesthetics | MISCL000015 | 49.58 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 84 | AGT levels | PROLV000059 | 49.37 | Protein levels | Hepatocyte | 53 | 2 | 5 | 10 | |
| 85 | Grain and bakery preference | DTSUP000013 | 49.27 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 86 | Self-rated health | MISCL000013 | 48.92 | Miscellaneous | Neural / glial | 29 | 5 | 10 | 17 | |
| 87 | Alcohol consumption | PSYCH000041 | 48.90 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 88 | Supplement use, mineral or vitamin, none | DTSUP000027 | 48.76 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 89 | Smoking behaviour | PSYCH000046 | 48.71 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 90 | Dietary restriction | DTSUP000009 | 48.20 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 91 | Taste preference | DTSUP000023 | 47.53 | Diet and Supplement | Neural / glial | 83 | 3 | 6 | 17 | |
| 92 | Premature cardiac beat | CARDI000023 | 47.05 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 93 | Social relationships | SOCIO000021 | 47.00 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 94 | Household income | SOCIO000026 | 46.80 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 95 | Supplement use, dietary | DTSUP000024 | 46.42 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 96 | Insomnia | PSYCH000038 | 45.63 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 97 | Metabolic syndrome | METBL000015 | 44.47 | Metabolic | Neural / glial | 850 | 7 | 13 | 19 | |
| 98 | Tinnitus | AUDIO000014 | 44.38 | Auditory | Neural / glial | 2 | 4 | 8 | 12 | |
| 99 | PGLS levels | PROLV001545 | 44.33 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 100 | Hearing difficulty | AUDIO000012 | 43.55 | Auditory | Neural / glial | 134 | 1 | 7 | 6 | |
| 101 | Cellulitis and abscess | IMMUN000055 | 42.99 | Immunologic | Neural / glial | 5 | 4 | 11 | 20 | |
| 102 | Sphingolipids | LIPID000071 | 42.86 | Lipids | Neural / glial | 0 | 1 | 4 | 7 | |
| 103 | Sleep duration | PSYCH000040 | 42.58 | Psychiatric | Neural / glial | 9 | 6 | 14 | 17 | |
| 104 | Medication, cardiovascular | VASCU000036 | 42.18 | Vascular | Neural / glial | 11 | 2 | 4 | 16 | |
| 105 | Beverage preference | DTSUP000001 | 41.49 | Diet and Supplement | Neural / glial | 155 | 3 | 9 | 15 | |
| 106 | Transport mode | BEHAV000009 | 40.71 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 107 | Passive smoking | MISCL000007 | 40.64 | Miscellaneous | Neural / glial | 0 | 3 | 8 | 18 | |
| 108 | Frailty, general | MISCL000039 | 40.58 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 109 | Irritable bowel syndrome | GASTR000004 | 40.13 | Gastrointestinal | Neural / glial | 3 | 2 | 7 | 23 | |
| 110 | Soft tissue disorder | MSKEL000069 | 40.06 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 111 | Stressful life events | PSYCH000053 | 39.92 | Psychiatric | Neural / glial | 0 | 5 | 9 | 21 | |
| 112 | Respiratory symptom | RESPI000032 | 39.78 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 113 | Depressive symptoms | PSYCH000026 | 39.27 | Psychiatric | Neural / glial | 28 | 2 | 7 | 14 | |
| 114 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 39.16 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 115 | Narcolepsy | NEURO000036 | 38.91 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 116 | Disability allowance | SOCIO000019 | 38.75 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 117 | Physical activity | BEHAV000007 | 38.64 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 118 | Consultant specialty, gastroenterology | GASTR000007 | 38.51 | Gastrointestinal | Neural / glial | 0 | 5 | 12 | 16 | |
| 119 | KLK6/PTPRN2 ratio | PRORT001410 | 38.45 | Protein ratios | Neural / glial | 6 | 4 | 10 | 13 | |
| 120 | Hip circumference | BMORP000011 | 38.21 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 121 | Vehicle ownership | SOCIO000015 | 38.11 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 122 | Dietary pattern | DTSUP000007 | 37.82 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 123 | Risk-taking behaviour | BEHAV000013 | 37.39 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 124 | Parkinson disease | NEURO000022 | 36.93 | Neurologic | Neural / glial | 25 | 6 | 11 | 24 | |
| 125 | Age at onset of walking | NEURO000023 | 36.73 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 126 | FSTL3 levels | PROLV000831 | 36.60 | Protein levels | Neural / glial | 17 | 2 | 3 | 8 | |
| 127 | Medication use, pain etc, none | MISCL000032 | 36.48 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 128 | Depression | PSYCH000024 | 36.28 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 129 | Mood disorder | PSYCH000028 | 36.19 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 130 | Pain, generic | MSKEL000035 | 36.14 | Musculoskeletal | Neural / glial | 4 | 4 | 17 | 25 | |
| 131 | Sodium | METAB000050 | 36.03 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 132 | Leg mass | BCOMP000017 | 35.72 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 133 | Chest pain | CARDI000052 | 35.71 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 134 | Supplement use, mineral or vitamin | DTSUP000026 | 34.88 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 135 | Social and economic stability | SOCIO000028 | 34.73 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 136 | Urinary tract infection | IMMUN000074 | 34.22 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 137 | Alcohol preference | PSYCH000042 | 33.94 | Psychiatric | Neural / glial | 14 | 4 | 10 | 11 | |
| 138 | CHGB levels | PROLV000427 | 33.71 | Protein levels | Neural / glial | 3 | 2 | 6 | 15 | |
| 139 | Oesophageal disorder | GASTR000050 | 33.03 | Gastrointestinal | Neural / glial | 15 | 2 | 10 | 21 | |
| 140 | Medication use | MISCL000037 | 32.82 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 141 | GLB1/GUSB ratio | PRORT001215 | 32.78 | Protein ratios | Hepatocyte | 40 | 2 | 8 | 12 | |
| 142 | Occupation | SOCIO000006 | 32.71 | Socioeconomic | Neural / glial | 1 | 1 | 4 | 6 | |
| 143 | Gastrointestinal endoscopy | GASTR000042 | 32.57 | Gastrointestinal | Neural / glial | 13 | 2 | 8 | 11 | |
| 144 | Housing tenure | SOCIO000012 | 32.44 | Socioeconomic | Neural / glial | 0 | 5 | 9 | 20 | |
| 145 | Gait abnormality | NEURO000014 | 32.30 | Neurologic | Neural / glial | 0 | 4 | 11 | 17 | |
| 146 | Corrective lens use | OPHTH000032 | 32.25 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 147 | Prospective memory | PSYCH000009 | 32.22 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 148 | Dietary change | DTSUP000006 | 31.90 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 0 | |
| 149 | APOE levels | PROLV000124 | 31.78 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 150 | Fatty acids, docosahexaenoic acid | LIPID000020 | 31.56 | Lipids | Hepatocyte | 789 | 4 | 9 | 16 | |
| 151 | MGAT2 levels | PROLV001308 | 31.43 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 152 | Anxiety | PSYCH000022 | 31.34 | Psychiatric | Neural / glial | 45 | 4 | 8 | 19 | |
| 153 | Medication, GERD | GASTR000014 | 31.22 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 154 | Intestinal disorder | GASTR000012 | 30.96 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 155 | PPIE levels | PROLV001607 | 30.71 | Protein levels | Neural / glial | 0 | 1 | 7 | 9 | |
| 156 | PALM2 levels | PROLV001490 | 30.38 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 157 | Digestive system symptoms | GASTR000044 | 30.28 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 158 | Wellbeing | PSYCH000056 | 30.16 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 159 | Sweets preference | DTSUP000019 | 30.00 | Diet and Supplement | Neural / glial | 88 | 4 | 7 | 13 | |
| 160 | DCXR/GSTA1 ratio | PRORT000876 | 29.40 | Protein ratios | Neural / glial | 31 | 6 | 11 | 16 | |
| 161 | Trauma exposure | PSYCH000054 | 28.61 | Psychiatric | Neural / glial | 32 | 2 | 6 | 14 | |
| 162 | Study participation | BEHAV000004 | 28.52 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 163 | Handedness | BEHAV000003 | 28.39 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 164 | Auditory performance | AUDIO000009 | 27.76 | Auditory | Neural / glial | 0 | 4 | 11 | 26 | |
| 165 | ERBB2/GUSB ratio | PRORT001043 | 27.64 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 166 | Legume preference | DTSUP000014 | 27.64 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 18 | |
| 167 | Beta-cell function | METBL000036 | 26.93 | Metabolic | Neural / glial | 0 | 1 | 5 | 13 | |
| 168 | Major depressive disorder | PSYCH000027 | 26.82 | Psychiatric | Neural / glial | 0 | 2 | 6 | 6 | |
| 169 | Medication, analgesic | MISCL000034 | 26.80 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 170 | MOG/PTPRN2 ratio | PRORT001551 | 26.38 | Protein ratios | Neural / glial | 28 | 3 | 3 | 10 | |
| 171 | Dairy preference | DTSUP000011 | 26.31 | Diet and Supplement | Neural / glial | 85 | 4 | 5 | 20 | |
| 172 | Mental distress | PSYCH000014 | 24.93 | Psychiatric | Muscle / cardiac | 2 | 7 | 11 | 20 | |
| 173 | Urinary system disorder | NEPHR000005 | 24.92 | Nephrourologic | Neural / glial | 1 | 2 | 7 | 9 | |
| 174 | Loose teeth | DENTA000012 | 24.84 | Dental | Neural / glial | 1 | 2 | 7 | 12 | |
| 175 | Stressful life events, none | PSYCH000050 | 24.70 | Psychiatric | Neural / glial | 7 | 6 | 15 | 10 | |
| 176 | Sciatica | NEURO000033 | 24.40 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 177 | Paroxysmal neurological disorder | NEURO000035 | 24.32 | Neurologic | Neural / glial | 21 | 3 | 4 | 10 | |
| 178 | CAMK1D levels | PROLV000259 | 24.13 | Protein levels | Hepatocyte | 9 | 2 | 8 | 12 | |
| 179 | Functional gastrointestinal disorder | GASTR000003 | 22.98 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 180 | Pain, chronic | MSKEL000034 | 22.65 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 181 | BLVRB/HMBS ratio | PRORT000243 | 22.13 | Protein ratios | Neural / glial | 14 | 5 | 14 | 29 | |
| 182 | Central serous chorioretinopathy | OPHTH000035 | 21.96 | Ophthalmic | Hepatocyte | 11 | 2 | 5 | 15 | |
| 183 | SMNDC1 levels | PROLV001898 | 21.82 | Protein levels | Neural / glial | 5 | 4 | 12 | 34 | |
| 184 | Cerebral ischaemia | VASCU000012 | 21.69 | Vascular | Neural / glial | 1 | 2 | 7 | 5 | |
| 185 | ELOA levels | PROLV000701 | 21.15 | Protein levels | Neural / glial | 5 | 6 | 12 | 31 | |
| 186 | Basal metabolic rate | METBL000007 | 20.90 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 187 | Weight-to-muscle ratio | BCOMP000010 | 20.85 | Body composition | Neural / glial | 1 | 5 | 8 | 19 | |
| 188 | Liver volume | HPBIL000025 | 20.75 | Hepatopancreatobiliary | Myeloid | 26 | 4 | 13 | 12 | |
| 189 | Hearing difficulty, none | AUDIO000005 | 20.69 | Auditory | Neural / glial | 33 | 2 | 8 | 10 | |
| 190 | Rotator cuff disorder | MSKEL000066 | 20.58 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 8 | |
| 191 | SPON2 levels | PROLV001937 | 20.53 | Protein levels | Hepatocyte | 44 | 4 | 9 | 17 | |
| 192 | CEBPB/PXN ratio | PRORT000592 | 20.42 | Protein ratios | Neural / glial | 0 | 3 | 6 | 17 | |
| 193 | GLRX2 levels | PROLV000897 | 20.33 | Protein levels | Neural / glial | 0 | 2 | 6 | 17 | |
| 194 | Alpha-1-antitrypsin deficiency | RESPI000005 | 19.86 | Respiratory | Granulosa cell | 4 | 3 | 10 | 14 | |
| 195 | Cortical thickness | NIMAG000010 | 19.73 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 196 | Erectile dysfunction | VASCU000048 | 19.56 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 197 | Cough | RESPI000027 | 18.69 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 198 | Gastritis and duodenitis | GASTR000049 | 18.67 | Gastrointestinal | Neural / glial | — | 2 | 7 | 5 | |
| 199 | Pain, joint | MSKEL000036 | 18.65 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 200 | BCL2 levels | PROLV000185 | 18.62 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 201 | TPI1 levels | PROLV002093 | 18.49 | Protein levels | Neural / glial | 1 | 1 | 13 | 20 | |
| 202 | HGF levels | PROLV000965 | 18.40 | Protein levels | Neural / glial | 29 | 4 | 13 | 15 | |
| 203 | Physical activity, none | BEHAV000005 | 18.25 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 204 | Bowel function | GASTR000002 | 18.07 | Gastrointestinal | Neural / glial | 18 | 5 | 9 | 11 | |
| 205 | Spread preference | DTSUP000018 | 18.02 | Diet and Supplement | Neural / glial | 14 | 2 | 6 | 13 | |
| 206 | Sleep apnoea | RESPI000035 | 17.96 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 207 | Pregnancy termination | BEHAV000010 | 17.77 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 208 | Headache | NEURO000009 | 17.72 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 209 | Arm mass | BCOMP000014 | 17.66 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 210 | CRKL/DBNL ratio | PRORT000762 | 17.63 | Protein ratios | Muscle / cardiac | 2 | 5 | 11 | 23 | |
| 211 | HRG levels | PROLV000988 | 17.58 | Protein levels | Neural / glial | 68 | 4 | 12 | 26 | |
| 212 | Pain, back | MSKEL000033 | 17.49 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 213 | Suicidal behaviour | PSYCH000037 | 17.44 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 214 | Sleep disorder | PSYCH000039 | 17.28 | Psychiatric | Neural / glial | 13 | 1 | 4 | 4 | |
| 215 | Housing type | SOCIO000013 | 16.87 | Socioeconomic | Neural / glial | — | 7 | 14 | 22 | |
| 216 | Exercise workload | CARDI000024 | 16.85 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 217 | CD109 levels | PROLV000309 | 16.70 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 218 | Gestational age at birth | REPRO000040 | 16.70 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 219 | Parental longevity | AGING000003 | 16.67 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 220 | Mental disorder | PSYCH000013 | 16.62 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 221 | Surgical history | MISCL000031 | 16.60 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 222 | Venous insufficiency | VASCU000065 | 16.56 | Vascular | Neural / glial | 1 | 1 | 4 | 12 | |
| 223 | Circulatory disorder | VASCU000025 | 16.50 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 224 | Citrulline | METAB000020 | 16.50 | Metabolites | Muscle / cardiac | 0 | 1 | 6 | 5 | |
| 225 | PTPRN2/RTBDN ratio | PRORT001724 | 16.47 | Protein ratios | Neural / glial | 7 | 2 | 6 | 18 | |
| 226 | Hearing loss, sensorineural | AUDIO000008 | 16.44 | Auditory | Neural / glial | 38 | 2 | 9 | 8 | |
| 227 | Pain, none | MSKEL000041 | 16.41 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 228 | NAGA levels | PROLV001371 | 16.39 | Protein levels | Myeloid | 46 | 5 | 9 | 12 | |
| 229 | Cutaneous abscess | IMMUN000057 | 16.34 | Immunologic | Neural / glial | 0 | 2 | 7 | 15 | |
| 230 | NSFL1C/RILP ratio | PRORT001600 | 16.25 | Protein ratios | Neural / glial | 57 | 6 | 11 | 31 | |
| 231 | RNASEH2A levels | PROLV001741 | 16.23 | Protein levels | Neural / glial | 5 | 3 | 11 | 24 | |
| 232 | AXIN1/MAVS ratio | PRORT000175 | 16.23 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 233 | Birth weight availability | MISCL000005 | 16.11 | Miscellaneous | Neural / glial | 11 | 5 | 10 | 22 | |
| 234 | Oestrogen metabolite | ENDOC000009 | 16.00 | Endocrine | Hepatocyte | 6 | 2 | 8 | 12 | |
| 235 | Joint injection | MSKEL000048 | 15.74 | Musculoskeletal | Neural / glial | 0 | 5 | 14 | 36 | |
| 236 | FGFR4 levels | PROLV000802 | 15.46 | Protein levels | Hepatocyte | 102 | 2 | 8 | 24 | |
| 237 | ST6GALNAC2 levels | PROLV001954 | 15.32 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 238 | PCOLCE levels | PROLV001510 | 15.25 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 239 | Shoulder lesion | MSKEL000068 | 15.19 | Musculoskeletal | B / plasma cell | 22 | 1 | 5 | 15 | |
| 240 | Smoking dependency | PSYCH000047 | 15.15 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 241 | PYY levels | PROLV001690 | 15.15 | Protein levels | Neural / glial | 56 | 2 | 8 | 11 | |
| 242 | Frailty, unhealthy lifestyle | BEHAV000002 | 15.09 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 243 | Alanine metabolite | METAB000001 | 15.06 | Metabolites | Gastrointestinal epithelium | 0 | 2 | 9 | 7 | |
| 244 | Liver fat | HPBIL000023 | 14.93 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 245 | RND3 levels | PROLV001743 | 14.76 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 246 | Healthcare cost | SOCIO000025 | 14.76 | Socioeconomic | Neural / glial | 27 | 3 | 8 | 12 | |
| 247 | C1QTNF1 levels | PROLV000224 | 14.71 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 248 | Pre-existing hypertension, pregnancy | VASCU000044 | 14.62 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 249 | Hearing loss | AUDIO000013 | 14.49 | Auditory | Neural / glial | 54 | 1 | 3 | 11 | |
| 250 | Pain, limb | MSKEL000037 | 14.42 | Musculoskeletal | B / plasma cell | 1 | 5 | 10 | 20 | |
| 251 | CHGA levels | PROLV000426 | 14.38 | Protein levels | Neural / glial | 33 | 2 | 5 | 12 | |
| 252 | Medication, anti-depressant | PSYCH000019 | 14.33 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 253 | Peripheral neuropathy | NEURO000032 | 14.08 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 254 | Medication, anti-malarial | IMMUN000083 | 14.01 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 255 | Inflammation and poor diet | MISCL000001 | 13.81 | Miscellaneous | Myeloid | 166 | 5 | 8 | 19 | |
| 256 | SFRP2 levels | PROLV001845 | 13.81 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 257 | Pain, multi-site | MSKEL000038 | 13.68 | Musculoskeletal | Neural / glial | 13 | 5 | 10 | 28 | |
| 258 | EIF4G1/FKBP5 ratio | PRORT001008 | 13.63 | Protein ratios | Hepatocyte | 20 | 1 | 6 | 10 | |
| 259 | Acquired absence of organs | MISCL000027 | 13.59 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 260 | Pregnancy complication, general | REPRO000029 | 13.45 | Reproductive | Hepatocyte | 3 | 2 | 6 | 12 | |
| 261 | Operation, cardiac | CARDI000046 | 13.43 | Cardiac | Muscle / cardiac | 20 | 2 | 5 | 7 | |
| 262 | LEPR/NTRK2 ratio | PRORT001448 | 13.33 | Protein ratios | Neural / glial | 24 | 4 | 10 | 21 | |
| 263 | Pregnancy complication, preterm labour | REPRO000034 | 13.11 | Reproductive | Lymphocyte | 0 | 2 | 17 | 25 | |
| 264 | ATOX1/TMSB10 ratio | PRORT000153 | 12.99 | Protein ratios | Myeloid | 4 | 3 | 9 | 17 | |
| 265 | Administrative status | MISCL000021 | 12.91 | Miscellaneous | Neural / glial | 0 | 2 | 8 | 13 | |
| 266 | Occupational attainment | SOCIO000007 | 12.86 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 267 | UBAC1 levels | PROLV002132 | 12.79 | Protein levels | Muscle / cardiac | 4 | 2 | 6 | 11 | |
| 268 | CFHR4 levels | PROLV000416 | 12.78 | Protein levels | Hepatocyte | 61 | 2 | 9 | 16 | |
| 269 | Abdominal adiposity | BCOMP000003 | 12.75 | Body composition | Neural / glial | 18 | 2 | 6 | 21 | |
| 270 | FAM151A levels | PROLV000760 | 12.69 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 271 | ZNRF4 levels | PROLV002214 | 12.44 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 272 | Alcohol use disorder | PSYCH000044 | 12.43 | Psychiatric | Neural / glial | 2 | 3 | 5 | 12 | |
| 273 | MAP4K5/TBCB ratio | PRORT001491 | 12.39 | Protein ratios | Neural / glial | 5 | 4 | 8 | 23 | |
| 274 | PRR15 levels | PROLV001641 | 12.38 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 275 | HLA-DQA2 levels | PROLV000974 | 12.25 | Protein levels | Neural / glial | 5 | 4 | 7 | 9 | |
| 276 | SPOCK2 levels | PROLV001935 | 12.20 | Protein levels | Hepatocyte | 5 | 2 | 6 | 12 | |
| 277 | NPDC1/TAFA5 ratio | PRORT001595 | 12.14 | Protein ratios | Vascular | 24 | 4 | 9 | 29 | |
| 278 | CA1/CA2 ratio | PRORT000267 | 12.08 | Protein ratios | Muscle / cardiac | 0 | 1 | 7 | 11 | |
| 279 | Hospital admission | MISCL000022 | 12.08 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 280 | Working hours | SOCIO000009 | 12.04 | Socioeconomic | Myeloid | 0 | 2 | 7 | 7 | |
| 281 | ARSA/GUSB ratio | PRORT000143 | 12.02 | Protein ratios | Hepatocyte | 21 | 4 | 9 | 26 | |
| 282 | Hashimoto thyroiditis | IMMUN000028 | 11.99 | Immunologic | Neural / glial | — | 2 | 4 | 8 | |
| 283 | Hearing loss, age-related | AUDIO000006 | 11.97 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 284 | Weight change | BMORP000016 | 11.95 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 285 | COL6A3/CST3 ratio | PRORT000696 | 11.91 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 286 | PTPRB levels | PROLV001673 | 11.91 | Protein levels | Vascular | 89 | 3 | 11 | 17 | |
| 287 | ESR1 levels | PROLV000735 | 11.88 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 288 | Open wound | DERMA000043 | 11.85 | Dermatologic | Neural / glial | 1 | 3 | 7 | 6 | |
| 289 | Ataxia | NEURO000013 | 11.60 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 290 | Employment status | SOCIO000005 | 11.57 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 291 | FGR levels | PROLV000804 | 11.56 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 292 | MSRA/PRDX5 ratio | PRORT001562 | 11.56 | Protein ratios | Neural / glial | 0 | 5 | 14 | 44 | |
| 293 | GPD1 levels | PROLV000921 | 11.48 | Protein levels | Neural / glial | 0 | 3 | 7 | 11 | |
| 294 | RLN2 levels | PROLV001736 | 11.45 | Protein levels | Muscle / cardiac | 6 | 4 | 10 | 24 | |
| 295 | Medication, chronic lung disease | RESPI000006 | 11.37 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 296 | MLN/TNFRSF12A ratio | PRORT001539 | 11.37 | Protein ratios | Neural / glial | 18 | 1 | 3 | 4 | |
| 297 | SELPLG levels | PROLV001806 | 11.30 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 298 | Pain, neck and shoulder | MSKEL000039 | 11.29 | Musculoskeletal | Myeloid | 0 | 4 | 9 | 20 | |
| 299 | Social trust | SOCIO000023 | 11.28 | Socioeconomic | Stromal / connective | 0 | 5 | 12 | 19 | |
| 300 | Alcoholic liver disease | HPBIL000033 | 11.21 | Hepatopancreatobiliary | Neural / glial | 1 | 3 | 14 | 15 | |
| 301 | CALCOCO1/IKBKG ratio | PRORT000295 | 11.16 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 302 | CNTN4 levels | PROLV000478 | 11.16 | Protein levels | Myeloid | 28 | 0 | 1 | 5 | |
| 303 | CNTNAP2/DPP6 ratio | PRORT000690 | 11.14 | Protein ratios | Neural / glial | 0 | 2 | 13 | 27 | |
| 304 | Brain age gap | NIMAG000004 | 11.02 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 305 | BLVRB/HBQ1 ratio | PRORT000242 | 11.02 | Protein ratios | Muscle / cardiac | 11 | 3 | 8 | 13 | |
| 306 | Potassium | METAB000049 | 10.97 | Metabolites | Muscle / cardiac | 178 | 0 | 4 | 5 | |
| 307 | Psychiatric disorder | PSYCH000016 | 10.94 | Psychiatric | Neural / glial | 0 | 2 | 7 | 11 | |
| 308 | EHMT2 levels | PROLV000691 | 10.87 | Protein levels | Granulosa cell | 1 | 3 | 10 | 14 | |
| 309 | FXN/METAP1D ratio | PRORT001194 | 10.73 | Protein ratios | Neural / glial | 3 | 3 | 7 | 19 | |
| 310 | TIGIT levels | PROLV002034 | 10.70 | Protein levels | Lymphocyte | 28 | 2 | 15 | 23 | |
| 311 | Diabetes, type 2 with complication | METBL000033 | 10.69 | Metabolic | Neural / glial | 118 | 2 | 8 | 8 | |
| 312 | CTSH levels | PROLV000565 | 10.63 | Protein levels | Hepatocyte | 29 | 2 | 8 | 17 | |
| 313 | Heart rate | CARDI000021 | 10.60 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 314 | CREG1/GUSB ratio | PRORT000751 | 10.49 | Protein ratios | Hepatocyte | 40 | 2 | 12 | 14 | |
| 315 | Epilepsy | NEURO000034 | 10.43 | Neurologic | Myeloid | 0 | 2 | 5 | 19 | |
| 316 | CD84 levels | PROLV000359 | 10.41 | Protein levels | Neural / glial | 16 | 3 | 10 | 8 | |
| 317 | CRIP2 levels | PROLV000523 | 10.36 | Protein levels | Myeloid | 32 | 5 | 13 | 19 | |
| 318 | RBP7 levels | PROLV001713 | 10.34 | Protein levels | Neural / glial | 36 | 3 | 9 | 11 | |
| 319 | CEP85/ZBTB16 ratio | PRORT000604 | 10.04 | Protein ratios | Muscle / cardiac | 20 | 3 | 12 | 18 | |
| 320 | Family history, chronic disease | MISCL000009 | 10.03 | Miscellaneous | Vascular | 0 | 5 | 13 | 8 | |
| 321 | DECR1/MAP2K6 ratio | PRORT000882 | 10.02 | Protein ratios | Muscle / cardiac | 19 | 3 | 10 | 16 | |
| 322 | Endocrine gland disorder | ENDOC000003 | 9.99 | Endocrine | Neural / glial | 0 | 3 | 5 | 13 | |
| 323 | Migraine | NEURO000010 | 9.99 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 324 | Amyotrophic lateral sclerosis, ALS | NEURO000017 | 9.98 | Neurologic | Myeloid | 13 | 1 | 4 | 7 | |
| 325 | WFDC5 levels | PROLV002190 | 9.89 | Protein levels | Hepatocyte | 0 | 2 | 9 | 11 | |
| 326 | MAX/TDRKH ratio | PRORT001504 | 9.87 | Protein ratios | Myeloid | 0 | 4 | 11 | 11 | |
| 327 | LAYN/PTPRN2 ratio | PRORT001433 | 9.84 | Protein ratios | Neural / glial | 5 | 2 | 13 | 28 | |
| 328 | CCL25/PRSS27 ratio | PRORT000353 | 9.74 | Protein ratios | Lymphocyte | 1 | 2 | 9 | 18 | |
| 329 | Ocular alignment procedures | OPHTH000026 | 9.68 | Ophthalmic | Neural / glial | 1 | 2 | 5 | 18 | |
| 330 | Brain functional connectivity | NIMAG000002 | 9.45 | Neuroimaging | Neural / glial | 0 | 0 | 0 | 0 | |
| 331 | NCR3 levels | PROLV001383 | 9.39 | Protein levels | Adipose | — | 3 | 10 | 28 | |
| 332 | Cerebellar volume | NIMAG000019 | 9.36 | Neuroimaging | Myeloid | 12 | 0 | 0 | 1 | |
| 333 | Cancer, Oropharynx | MALIG000022 | 9.26 | Malignancy | Neural / glial | 0 | 6 | 13 | 22 | |
| 334 | RELL1 levels | PROLV001721 | 9.22 | Protein levels | Neural / glial | 3 | 2 | 4 | 14 | |
| 335 | Complement system disorder | IMMUN000048 | 9.16 | Immunologic | Hepatocyte | 4 | 1 | 5 | 8 | |
| 336 | CELSR2 levels | PROLV000398 | 9.09 | Protein levels | Muscle / cardiac | 14 | 2 | 9 | 15 | |
| 337 | CST3/TAFA5 ratio | PRORT000787 | 8.92 | Protein ratios | Myeloid | 1 | 3 | 10 | 9 | |
| 338 | Medication, antimigraine | NEURO000011 | 8.91 | Neurologic | Neural / glial | 0 | 2 | 7 | 8 | |
| 339 | ARNT levels | PROLV000144 | 8.91 | Protein levels | Myeloid | 24 | 3 | 9 | 11 | |
| 340 | Substance use | PSYCH000049 | 8.87 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 341 | Refractive errors | OPHTH000034 | 8.83 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 342 | F8 levels | PROLV000749 | 8.82 | Protein levels | Neural / glial | 2 | 2 | 6 | 11 | |
| 343 | DCXR/SCLY ratio | PRORT000878 | 8.82 | Protein ratios | Hepatocyte | 5 | 2 | 8 | 12 | |
| 344 | Medication, proton pump inhibitor | GASTR000017 | 8.82 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 345 | CNTN3/NCS1 ratio | PRORT000687 | 8.78 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 16 | |
| 346 | ATG4A/TPMT ratio | PRORT000150 | 8.75 | Protein ratios | Neural / glial | 0 | 3 | 7 | 13 | |
| 347 | Heart failure, congestive | CARDI000004 | 8.74 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 348 | PDCD6IP levels | PROLV001519 | 8.74 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 18 | |
| 349 | CD99/KITLG ratio | PRORT000534 | 8.69 | Protein ratios | Hepatocyte | 32 | 1 | 8 | 13 | |
| 350 | Vitreous disorder | OPHTH000047 | 8.61 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 351 | ARG1 levels | PROLV000134 | 8.61 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 352 | PER3 levels | PROLV001537 | 8.58 | Protein levels | Muscle / cardiac | 5 | 3 | 10 | 17 | |
| 353 | CIAPIN1/SNX9 ratio | PRORT000617 | 8.54 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 354 | Sex-differentiated cardiometabolic traits | MISCL000002 | 8.52 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 355 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 8.52 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 356 | Lysophosphatidylethanolamines | LIPID000055 | 8.50 | Lipids | Hepatocyte | 10 | 1 | 3 | 18 | |
| 357 | Gut microbial abundance, Microvirga | GASTR000029 | 8.49 | Gastrointestinal | Melanocyte | 0 | 7 | 10 | 14 | |
| 358 | CCBL2 levels | PROLV000274 | 8.48 | Protein levels | Neural / glial | 0 | 0 | 7 | 13 | |
| 359 | Retirement wellbeing | SOCIO000027 | 8.47 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 360 | Medication, analgesic or antidepressant | MISCL000033 | 8.42 | Miscellaneous | Lymphocyte | 0 | 3 | 16 | 43 | |
| 361 | Financial satisfaction | SOCIO000024 | 8.41 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 362 | ECHS1 levels | PROLV000671 | 8.35 | Protein levels | Hepatocyte | 32 | 4 | 12 | 21 | |
| 363 | Cerebrovascular disease | VASCU000013 | 8.33 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 364 | Dentures | DENTA000006 | 8.29 | Dental | Neural / glial | 0 | 3 | 7 | 16 | |
| 365 | Consultant specialty, general medicine | MISCL000016 | 8.17 | Miscellaneous | Neural / glial | 2 | 2 | 4 | 6 | |
| 366 | Occupational respiratory symptoms | RESPI000030 | 8.17 | Respiratory | Neural / glial | 0 | 1 | 4 | 11 | |
| 367 | Cardiac pacemaker | CARDI000049 | 8.16 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 368 | Intervertebral disc disorder | MSKEL000076 | 8.11 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 369 | Vitiligo | IMMUN000046 | 8.11 | Immunologic | Neural / glial | — | 0 | 3 | 6 | |
| 370 | PMVK/PRTFDC1 ratio | PRORT001693 | 8.06 | Protein ratios | Muscle / cardiac | 1 | 2 | 11 | 12 | |
| 371 | TNFSF10 levels | PROLV002075 | 8.06 | Protein levels | Hepatocyte | 153 | 2 | 7 | 11 | |
| 372 | Fatty acids, omega-3 | LIPID000024 | 8.06 | Lipids | Hepatocyte | 605 | 2 | 9 | 17 | |
| 373 | Ocular alignment disorder | OPHTH000023 | 8.02 | Ophthalmic | Myeloid | 9 | 4 | 9 | 17 | |
| 374 | ACY1/DCXR ratio | PRORT000019 | 8.01 | Protein ratios | Hepatocyte | 6 | 2 | 10 | 15 | |
| 375 | Leg impedance | BCOMP000016 | 7.99 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 376 | APOBR levels | PROLV000121 | 7.99 | Protein levels | Myeloid | 25 | 2 | 9 | 17 | |
| 377 | Snoring | RESPI000036 | 7.94 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 378 | CASP8/RILP ratio | PRORT000324 | 7.91 | Protein ratios | Hepatocyte | 2 | 3 | 8 | 19 | |
| 379 | Nerve root disorder | NEURO000030 | 7.87 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 380 | PSRC1 levels | PROLV001662 | 7.86 | Protein levels | Myeloid | 26 | 3 | 10 | 17 | |
| 381 | APOF levels | PROLV000125 | 7.85 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 382 | GMPR levels | PROLV000902 | 7.85 | Protein levels | Neural / glial | 10 | 4 | 7 | 18 | |
| 383 | ARHGEF10 levels | PROLV000140 | 7.82 | Protein levels | Stromal / connective | 25 | 7 | 14 | 21 | |
| 384 | MAP2K6/NT5C3A ratio | PRORT001486 | 7.82 | Protein ratios | Muscle / cardiac | 12 | 6 | 8 | 16 | |
| 385 | Pain, neck | MSKEL000040 | 7.77 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 386 | Restless legs syndrome, RLS | NEURO000012 | 7.74 | Neurologic | Neural / glial | 2 | 1 | 6 | 9 | |
| 387 | CUZD1 levels | PROLV000571 | 7.73 | Protein levels | Neural / glial | 1 | 3 | 9 | 19 | |
| 388 | HGF/PLAUR ratio | PRORT001285 | 7.66 | Protein ratios | Hepatocyte | 46 | 2 | 13 | 18 | |
| 389 | COX5B/METAP1D ratio | PRORT000717 | 7.49 | Protein ratios | Hepatocyte | 10 | 3 | 9 | 12 | |
| 390 | Abnormal heart sounds | CARDI000051 | 7.47 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 391 | Phosphatidylinositols | LIPID000061 | 7.43 | Lipids | Granulosa cell | 20 | 2 | 2 | 10 | |
| 392 | Polyamine metabolites | METAB000059 | 7.42 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 393 | IGFBP1 levels | PROLV001028 | 7.42 | Protein levels | Hepatocyte | 15 | 1 | 7 | 11 | |
| 394 | Temporomandibular joint disorder | MSKEL000022 | 7.37 | Musculoskeletal | Neural / glial | 0 | 1 | 6 | 11 | |
| 395 | BACH1/SNX9 ratio | PRORT000199 | 7.36 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 11 | |
| 396 | REN levels | PROLV001723 | 7.33 | Protein levels | Neural / glial | 2 | 0 | 3 | 8 | |
| 397 | S100A11 levels | PROLV001766 | 7.30 | Protein levels | Myeloid | 8 | 3 | 11 | 23 | |
| 398 | Testicular dysfunction | REPRO000016 | 7.29 | Reproductive | Hepatocyte | 14 | 3 | 12 | 33 | |
| 399 | Loud music exposure | MISCL000006 | 7.28 | Miscellaneous | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 400 | Wisdom tooth surgery | DENTA000005 | 7.25 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 401 | PPM1F levels | PROLV001611 | 7.19 | Protein levels | Lymphocyte | 9 | 3 | 8 | 21 | |
| 402 | SEMA3G levels | PROLV001808 | 7.18 | Protein levels | Hepatocyte | 80 | 1 | 6 | 8 | |
| 403 | UNC5D levels | PROLV002141 | 7.18 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 404 | Medication, bone metabolism | MSKEL000025 | 7.16 | Musculoskeletal | Lymphocyte | — | 2 | 10 | 27 | |
| 405 | Operation, reproductive | REPRO000042 | 7.14 | Reproductive | Hepatocyte | 9 | 0 | 3 | 7 | |
| 406 | BSG/PCDH1 ratio | PRORT000250 | 7.11 | Protein ratios | Neural / glial | 9 | 0 | 5 | 9 | |
| 407 | Luteinizing hormone | ENDOC000008 | 7.09 | Endocrine | Muscle / cardiac | 0 | 5 | 7 | 15 | |
| 408 | NOMO1 levels | PROLV001413 | 7.07 | Protein levels | Hepatocyte | 96 | 3 | 11 | 18 | |
| 409 | EIF4G1/MAVS ratio | PRORT001011 | 7.07 | Protein ratios | Myeloid | 22 | 3 | 9 | 16 | |
| 410 | PXN levels | PROLV001688 | 7.04 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 411 | Cancer, Stomach | MALIG000030 | 6.99 | Malignancy | Myeloid | 2 | 0 | 1 | 9 | |
| 412 | EFNA4/LAYN ratio | PRORT000990 | 6.93 | Protein ratios | Muscle / cardiac | 3 | 3 | 8 | 13 | |
| 413 | LEP levels | PROLV001199 | 6.92 | Protein levels | Neural / glial | 1 | 0 | 8 | 12 | |
| 414 | Family medical history, none | MISCL000010 | 6.91 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 415 | Urbanicity | SOCIO000029 | 6.91 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 416 | Diabetes, type 1 with complication | IMMUN000011 | 6.84 | Immunologic | Neural / glial | 14 | 0 | 2 | 7 | |
| 417 | Brain structural connectivity | NIMAG000007 | 6.82 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 418 | AKR1B1 levels | PROLV000072 | 6.81 | Protein levels | Stromal / connective | 11 | 7 | 10 | 27 | |
| 419 | EGLN1/FOXO1 ratio | PRORT001002 | 6.79 | Protein ratios | Hepatocyte | 4 | 4 | 10 | 21 | |
| 420 | NAGK levels | PROLV001372 | 6.77 | Protein levels | Muscle / cardiac | 78 | 3 | 13 | 23 | |
| 421 | COL15A1 levels | PROLV000483 | 6.76 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 422 | Hearing aid use | AUDIO000011 | 6.74 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 423 | Whole body impedance | BCOMP000007 | 6.74 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 424 | FOXO3 levels | PROLV000826 | 6.73 | Protein levels | Lymphocyte | 3 | 2 | 14 | 20 | |
| 425 | Frailty, metabolic problems | METBL000011 | 6.72 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 426 | MPHOSPH8/PSRC1 ratio | PRORT001554 | 6.71 | Protein ratios | Myeloid | 0 | 5 | 11 | 16 | |
| 427 | FEN1 levels | PROLV000789 | 6.68 | Protein levels | Neural / glial | 1 | 4 | 9 | 21 | |
| 428 | FADD/NCK2 ratio | PRORT001106 | 6.67 | Protein ratios | Neural / glial | 6 | 3 | 8 | 14 | |
| 429 | IL13RA1 levels | PROLV001047 | 6.65 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 430 | Frailty, multimorbidity | METBL000012 | 6.63 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 431 | CNPY4/STAT5B ratio | PRORT000681 | 6.63 | Protein ratios | Hepatocyte | 2 | 3 | 12 | 17 | |
| 432 | Medication, anti-cancer | MALIG000048 | 6.63 | Malignancy | Epithelial | 9 | 0 | 5 | 9 | |
| 433 | Fracture fixation | MSKEL000047 | 6.59 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 434 | Glutathione metabolites | METAB000006 | 6.58 | Metabolites | Neural / glial | 0 | 0 | 0 | 1 | |
| 435 | PAPL levels | PROLV001494 | 6.50 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 436 | Raynaud phenomenon | VASCU000060 | 6.50 | Vascular | Neural / glial | 2 | 0 | 5 | 12 | |
| 437 | GDF15 levels | PROLV000869 | 6.47 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 438 | EHD3 levels | PROLV000690 | 6.45 | Protein levels | Stromal / connective | 14 | 5 | 8 | 17 | |
| 439 | Lacrimal disorder | OPHTH000020 | 6.45 | Ophthalmic | Neural / glial | 0 | 0 | 2 | 11 | |
| 440 | Enthesopathy | MSKEL000061 | 6.42 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 441 | CCL28/PDGFB ratio | PRORT000354 | 6.42 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 6 | 27 | |
| 442 | Cardiomyopathy | CARDI000040 | 6.39 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 443 | Hypothyroxinemia | ENDOC000022 | 6.36 | Endocrine | Neural / glial | 0 | 3 | 11 | 16 | |
| 444 | PLAUR levels | PROLV001573 | 6.34 | Protein levels | Muscle / cardiac | 4 | 3 | 7 | 25 | |
| 445 | Ocular refraction | OPHTH000033 | 6.33 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 446 | Cardiovascular age gap | CARDI000001 | 6.30 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 447 | Retinal detachments and defects | OPHTH000039 | 6.29 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 448 | Patellar disorder | MSKEL000018 | 6.28 | Musculoskeletal | Neural / glial | 0 | 0 | 4 | 8 | |
| 449 | CD84/SEMA4D ratio | PRORT000527 | 6.26 | Protein ratios | Myeloid | 13 | 2 | 5 | 11 | |
| 450 | TPM2 levels | PROLV002095 | 6.26 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 451 | NPPB levels | PROLV001424 | 6.23 | Protein levels | Muscle / cardiac | 22 | 3 | 8 | 18 | |
| 452 | KLB levels | PROLV001148 | 6.23 | Protein levels | Hepatocyte | 138 | 1 | 9 | 23 | |
| 453 | Hospital stay | MISCL000024 | 6.16 | Miscellaneous | Neural / glial | 2 | 1 | 3 | 6 | |
| 454 | NRP1 levels | PROLV001434 | 6.15 | Protein levels | Hepatocyte | 128 | 2 | 10 | 21 | |
| 455 | L1CAM/SEZ6L ratio | PRORT001417 | 6.15 | Protein ratios | Myeloid | 3 | 1 | 8 | 17 | |
| 456 | ADHD | PSYCH000033 | 6.12 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 | |
| 457 | CA1 levels | PROLV000239 | 6.12 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 458 | GKN2 levels | PROLV000892 | 6.12 | Protein levels | Neural / glial | 14 | 0 | 5 | 4 | |
| 459 | LYZL2 levels | PROLV001255 | 6.06 | Protein levels | Hepatocyte | 5 | 3 | 10 | 21 | |
| 460 | White matter volume | NIMAG000028 | 6.06 | Neuroimaging | Neural / glial | 26 | 3 | 7 | 19 | |
| 461 | PATE4 levels | PROLV001498 | 6.04 | Protein levels | Muscle / cardiac | 0 | 2 | 9 | 19 | |
| 462 | Corpus callosum volume | NIMAG000021 | 6.02 | Neuroimaging | Neural / glial | 35 | 1 | 3 | 10 | |
| 463 | Body water mass | BCOMP000006 | 5.99 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 464 | Personality disorder | PSYCH000035 | 5.99 | Psychiatric | Hepatocyte | 0 | 1 | 5 | 15 | |
| 465 | Medication, beta blocker | VASCU000034 | 5.98 | Vascular | Vascular | 48 | 3 | 8 | 16 | |
| 466 | Cortical surface area | NIMAG000009 | 5.98 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 467 | Heme malignancy, Plasma cell | MALIG000046 | 5.97 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 468 | Secondary arthropathy | MSKEL000021 | 5.95 | Musculoskeletal | Hepatocyte | — | 2 | 9 | 13 | |
| 469 | Haemoglobin status | HEMAT000009 | 5.94 | Hematologic | Stromal / connective | 1 | 1 | 2 | 6 | |
| 470 | GP5 levels | PROLV000916 | 5.94 | Protein levels | Lymphocyte | 1 | 4 | 10 | 27 | |
| 471 | Synovium, tendon and bursa disorder | MSKEL000057 | 5.91 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 472 | GBP4 levels | PROLV000862 | 5.89 | Protein levels | Neural / glial | 4 | 3 | 11 | 25 | |
| 473 | Diabetes, with complication | METBL000035 | 5.88 | Metabolic | Neural / glial | 74 | 1 | 4 | 9 | |
| 474 | Low hand grip strength | MSKEL000032 | 5.81 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 475 | COL6A3/SPON2 ratio | PRORT000701 | 5.81 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 476 | RBP2 levels | PROLV001711 | 5.79 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 477 | Muscular dystrophy | MSKEL000028 | 5.76 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 478 | Phenylalanine metabolites | METAB000012 | 5.75 | Metabolites | Salivary epithelium | 4 | 0 | 4 | 6 | |
| 479 | METAP1D/PLXNA4 ratio | PRORT001521 | 5.74 | Protein ratios | Myeloid | 5 | 4 | 11 | 24 | |
| 480 | Hypertensive heart disease | CARDI000038 | 5.70 | Cardiac | Vascular | 23 | 0 | 1 | 8 | |
| 481 | CDH2 levels | PROLV000374 | 5.70 | Protein levels | Hepatocyte | 137 | 1 | 11 | 25 | |
| 482 | Viral wart | IMMUN000079 | 5.67 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 483 | LONP1 levels | PROLV001220 | 5.63 | Protein levels | Myeloid | 20 | 3 | 11 | 20 | |
| 484 | Brain general volume | NIMAG000015 | 5.62 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 485 | Consultant specialty, cardiology | CARDI000037 | 5.62 | Cardiac | Vascular | 51 | 4 | 13 | 19 | |
| 486 | Skin ulcer | DERMA000044 | 5.62 | Dermatologic | Granulosa cell | 1 | 1 | 2 | 6 | |
| 487 | AAGAB levels | PROLV000003 | 5.59 | Protein levels | Hepatocyte | 3 | 1 | 8 | 17 | |
| 488 | ADAMTSL4 levels | PROLV000037 | 5.59 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 489 | THTPA levels | PROLV002030 | 5.55 | Protein levels | Neural / glial | 0 | 4 | 9 | 37 | |
| 490 | PIK3IP1/RGMB ratio | PRORT001665 | 5.54 | Protein ratios | Neural / glial | 0 | 0 | 8 | 11 | |
| 491 | NT5C3A/PRDX5 ratio | PRORT001602 | 5.53 | Protein ratios | Myeloid | 0 | 2 | 8 | 14 | |
| 492 | ISLR2 levels | PROLV001101 | 5.53 | Protein levels | Granulosa cell | 65 | 4 | 11 | 16 | |
| 493 | Spondylosis | MSKEL000081 | 5.53 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 494 | EREG/TIMP3 ratio | PRORT001059 | 5.52 | Protein ratios | Myeloid | 5 | 2 | 13 | 18 | |
| 495 | SEZ6 levels | PROLV001840 | 5.52 | Protein levels | Neural / glial | 1 | 3 | 9 | 20 | |
| 496 | Fat-free mass | BCOMP000008 | 5.52 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 497 | MINPP1 levels | PROLV001317 | 5.51 | Protein levels | Neural / glial | 0 | 5 | 15 | 23 | |
| 498 | CDC37/SNAP29 ratio | PRORT000541 | 5.50 | Protein ratios | Myeloid | 18 | 4 | 13 | 31 | |
| 499 | Operation, urological | NEPHR000016 | 5.50 | Nephrourologic | Vascular | 16 | 0 | 6 | 18 | |
| 500 | Arrhythmia | CARDI000018 | 5.46 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 501 | Brain functional activity | NIMAG000001 | 5.46 | Neuroimaging | Hepatocyte | 9 | 0 | 1 | 6 | |
| 502 | ITIH4 levels | PROLV001119 | 5.45 | Protein levels | Hepatocyte | 94 | 2 | 8 | 17 | |
| 503 | Cortical volume | NIMAG000022 | 5.45 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 504 | NEFL levels | PROLV001389 | 5.40 | Protein levels | Hepatocyte | 16 | 2 | 7 | 16 | |
| 505 | BTN2A1/IL18BP ratio | PRORT000257 | 5.39 | Protein ratios | Myeloid | 15 | 2 | 12 | 8 | |
| 506 | SNX9/STIP1 ratio | PRORT001801 | 5.30 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 507 | GRHPR levels | PROLV000932 | 5.29 | Protein levels | Stromal / connective | 2 | 5 | 18 | 40 | |
| 508 | Ganglion cyst | MSKEL000065 | 5.28 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 509 | METAP1D/VASH1 ratio | PRORT001522 | 5.27 | Protein ratios | Hematopoietic progenitor | 4 | 2 | 5 | 11 | |
| 510 | MNDA levels | PROLV001329 | 5.25 | Protein levels | Muscle / cardiac | 1 | 4 | 10 | 20 | |
| 511 | NPTXR levels | PROLV001428 | 5.24 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 512 | Medication, anticoagulant | VASCU000030 | 5.23 | Vascular | Muscle / cardiac | 85 | 2 | 7 | 18 | |
| 513 | PON1 levels | PROLV001600 | 5.22 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 514 | IFI30 levels | PROLV001014 | 5.19 | Protein levels | Myeloid | 93 | 4 | 19 | 45 | |
| 515 | Operation, gastrointestinal | GASTR000039 | 5.19 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 516 | CHMP1A levels | PROLV000431 | 5.19 | Protein levels | Myeloid | 11 | 4 | 7 | 15 | |
| 517 | IGSF3 levels | PROLV001038 | 5.17 | Protein levels | Hepatocyte | 95 | 2 | 8 | 28 | |
| 518 | Peripheral nerve disorder | NEURO000031 | 5.15 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 519 | Personal medical history | MISCL000011 | 5.15 | Miscellaneous | Neural / glial | 0 | 0 | 3 | 7 | |
| 520 | Vertigo | AUDIO000021 | 5.14 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 521 | Family history, dyslipidaemia | METBL000010 | 5.12 | Metabolic | Hepatocyte | 64 | 1 | 6 | 10 | |
| 522 | MFGE8 levels | PROLV001307 | 5.10 | Protein levels | Myeloid | 168 | 3 | 13 | 26 | |
| 523 | CRNN levels | PROLV000528 | 5.09 | Protein levels | Cutaneous epithelium | 11 | 1 | 8 | 10 | |
| 524 | DOK2/PPP1R12A ratio | PRORT000941 | 5.01 | Protein ratios | Hepatocyte | 9 | 4 | 11 | 17 | |
| 525 | KLK6/MOG ratio | PRORT001409 | 5.00 | Protein ratios | Myeloid | 8 | 4 | 12 | 15 | |
| 526 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 5.00 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 527 | Neurological disorder | NEURO000008 | 5.00 | Neurologic | Muscle / cardiac | 0 | 1 | 7 | 7 | |
| 528 | ATRN levels | PROLV000163 | 4.96 | Protein levels | Vascular | 52 | 6 | 17 | 29 | |
| 529 | Tendinitis | MSKEL000070 | 4.94 | Musculoskeletal | Neural / glial | 0 | 1 | 3 | 9 | |
| 530 | BLVRB/HAGH ratio | PRORT000241 | 4.93 | Protein ratios | Neural / glial | 22 | 2 | 7 | 8 | |
| 531 | PLXNA4/SPRY2 ratio | PRORT001685 | 4.92 | Protein ratios | Hepatocyte | 22 | 5 | 11 | 23 | |
| 532 | CD40/ITGB5 ratio | PRORT000445 | 4.91 | Protein ratios | Myeloid | 8 | 2 | 9 | 17 | |
| 533 | Chalazion | OPHTH000017 | 4.90 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 534 | SNCA levels | PROLV001908 | 4.90 | Protein levels | Myeloid | 18 | 2 | 5 | 10 | |
| 535 | FAM174A levels | PROLV000763 | 4.88 | Protein levels | Adipose | 0 | 1 | 9 | 10 | |
| 536 | EFNA1/PIK3IP1 ratio | PRORT000989 | 4.87 | Protein ratios | Hepatocyte | 29 | 2 | 10 | 21 | |
| 537 | Blood disorder | HEMAT000040 | 4.86 | Hematologic | Myeloid | 1 | 3 | 8 | 12 | |
| 538 | Eyelid, lacrimal and orbital disorder | OPHTH000016 | 4.85 | Ophthalmic | Myeloid | — | 3 | 9 | 18 | |
| 539 | Bronchitis | RESPI000001 | 4.83 | Respiratory | Lymphocyte | 7 | 1 | 11 | 21 | |
| 540 | Duodenal ulcer | GASTR000047 | 4.79 | Gastrointestinal | Vascular | 27 | 0 | 4 | 4 | |
| 541 | Healthspan | AGING000004 | 4.78 | Aging | Hepatocyte | 12 | 1 | 12 | 12 | |
| 542 | CHI3L1/HSPG2 ratio | PRORT000610 | 4.77 | Protein ratios | Hepatocyte | 10 | 2 | 9 | 26 | |
| 543 | Body fat percentage, hormone-adjusted | BCOMP000001 | 4.77 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 544 | PCDH7 levels | PROLV001507 | 4.75 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 545 | FADD/PPP1R2 ratio | PRORT001109 | 4.74 | Protein ratios | Myeloid | 14 | 1 | 7 | 13 | |
| 546 | IL1R1 levels | PROLV001060 | 4.71 | Protein levels | Hepatocyte | 77 | 2 | 7 | 15 | |
| 547 | OPLAH levels | PROLV001471 | 4.71 | Protein levels | Lymphocyte | 8 | 0 | 7 | 13 | |
| 548 | Hospital discharge | MISCL000023 | 4.65 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 549 | STAMBP/WWP2 ratio | PRORT001817 | 4.64 | Protein ratios | Muscle / cardiac | 8 | 4 | 9 | 20 | |
| 550 | GAST levels | PROLV000857 | 4.62 | Protein levels | Salivary epithelium | 17 | 0 | 6 | 9 | |
| 551 | CLIC5 levels | PROLV000458 | 4.61 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 552 | IL22 levels | PROLV001066 | 4.61 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 553 | Gut microbial abundance, Prevotella | GASTR000031 | 4.60 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 11 | |
| 554 | TOP1 levels | PROLV002087 | 4.60 | Protein levels | Hepatocyte | 36 | 3 | 12 | 18 | |
| 555 | TSC22D1 levels | PROLV002113 | 4.60 | Protein levels | Stromal / connective | 4 | 2 | 9 | 10 | |
| 556 | Subcortical volume | NIMAG000026 | 4.59 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 557 | SCG2 levels | PROLV001784 | 4.58 | Protein levels | Hepatocyte | 20 | 1 | 7 | 11 | |
| 558 | Stimulant use disorder | PSYCH000048 | 4.58 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 559 | NCF2 levels | PROLV001380 | 4.57 | Protein levels | Muscle / cardiac | 2 | 2 | 7 | 14 | |
| 560 | Fatty acids metabolites | METAB000052 | 4.56 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 561 | Subarachnoid haemorrhage | VASCU000018 | 4.55 | Vascular | Granulosa cell | 0 | 0 | 5 | 6 | |
| 562 | Cataract | OPHTH000012 | 4.53 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 563 | Goitre | ENDOC000019 | 4.50 | Endocrine | Neural / glial | 28 | 0 | 1 | 8 | |
| 564 | FKBP5/MAP4K5 ratio | PRORT001157 | 4.49 | Protein ratios | Hepatocyte | 18 | 1 | 4 | 21 | |
| 565 | CXCL5/SERPINE1 ratio | PRORT000832 | 4.47 | Protein ratios | Myeloid | 0 | 5 | 10 | 14 | |
| 566 | FN1 levels | PROLV000819 | 4.42 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 567 | Hypothyroidism, congenital iodine deficiency | ENDOC000013 | 4.42 | Endocrine | Muscle / cardiac | 0 | 1 | 5 | 11 | |
| 568 | NBN levels | PROLV001376 | 4.41 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 569 | BCL2L2 levels | PROLV000189 | 4.41 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 570 | CCL20 levels | PROLV000287 | 4.39 | Protein levels | Myeloid | 32 | 1 | 3 | 2 | |
| 571 | Ornithine metabolites | METAB000011 | 4.32 | Metabolites | B / plasma cell | 0 | 2 | 9 | 9 | |
| 572 | Gut microbial abundance, CAG-177 | GASTR000020 | 4.29 | Gastrointestinal | Salivary epithelium | 0 | 0 | 7 | 5 | |
| 573 | PDGFA/SPARC ratio | PRORT001637 | 4.26 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 574 | PDGFA/SERPINE1 ratio | PRORT001635 | 4.26 | Protein ratios | Hematopoietic progenitor | 33 | 5 | 9 | 12 | |
| 575 | HS1BP3 levels | PROLV000989 | 4.25 | Protein levels | Stromal / connective | 24 | 6 | 12 | 24 | |
| 576 | KCTD5 levels | PROLV001131 | 4.25 | Protein levels | Lymphocyte | 3 | 1 | 12 | 19 | |
| 577 | CEBPB levels | PROLV000395 | 4.24 | Protein levels | Hepatocyte | 20 | 2 | 7 | 16 | |
| 578 | APOA2 levels | PROLV000118 | 4.23 | Protein levels | Hepatocyte | 134 | 3 | 9 | 20 | |
| 579 | IL1RAP levels | PROLV001062 | 4.22 | Protein levels | Hepatocyte | 96 | 2 | 12 | 13 | |
| 580 | Asparagine | METAB000018 | 4.20 | Metabolites | Hepatocyte | 6 | 2 | 10 | 14 | |
| 581 | Methionine metabolites | METAB000010 | 4.20 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 582 | BLMH/SERPINE1 ratio | PRORT000237 | 4.15 | Protein ratios | Myeloid | 17 | 2 | 16 | 22 | |
| 583 | Gut microbial abundance, Chromatiales | GASTR000024 | 4.15 | Gastrointestinal | Lymphocyte | 0 | 2 | 9 | 20 | |
| 584 | F9 levels | PROLV000750 | 4.14 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 585 | LCN2/PGLYRP1 ratio | PRORT001441 | 4.12 | Protein ratios | Lymphocyte | 75 | 3 | 16 | 48 | |
| 586 | Eye disorder | OPHTH000008 | 4.12 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 587 | FURIN levels | PROLV000835 | 4.11 | Protein levels | Myeloid | 29 | 3 | 8 | 13 | |
| 588 | DECR1/FXN ratio | PRORT000881 | 4.11 | Protein ratios | Muscle / cardiac | 6 | 5 | 9 | 22 | |
| 589 | ALPI levels | PROLV000082 | 4.08 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 590 | Memory disorder | PSYCH000006 | 4.08 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 591 | Ventricular volume | CARDI000015 | 4.08 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 592 | MAP4K5/TBCC ratio | PRORT001492 | 4.07 | Protein ratios | Myeloid | 1 | 4 | 12 | 30 | |
| 593 | CDKN1A/NCK2 ratio | PRORT000570 | 4.07 | Protein ratios | Vascular | 14 | 2 | 9 | 17 | |
| 594 | Heart rate variability | CARDI000022 | 4.06 | Cardiac | Muscle / cardiac | 10 | 2 | 4 | 15 | |
| 595 | EGFLAM levels | PROLV000686 | 4.04 | Protein levels | Hepatocyte | 53 | 2 | 10 | 16 | |
| 596 | C-reactive protein | HPBIL000026 | 4.03 | Hepatopancreatobiliary | Hepatocyte | 1,267 | 3 | 10 | 20 | |
| 597 | RILPL2 levels | PROLV001735 | 4.02 | Protein levels | Muscle / cardiac | 10 | 5 | 8 | 19 | |
| 598 | EXTL1 levels | PROLV000738 | 4.02 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 599 | Sleep-related movement disorder | NEURO000016 | 4.01 | Neurologic | Pancreatic epithelium | 4 | 0 | 8 | 5 | |
| 600 | Chronic respiratory disease | RESPI000003 | 4.00 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 601 | Retinal pigment epithelium thickness | OPHTH000042 | 4.00 | Ophthalmic | Myeloid | 6 | 3 | 12 | 13 | |
| 602 | ITGB1BP2/MITD1 ratio | PRORT001385 | 3.97 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 603 | Lysine metabolites | METAB000009 | 3.97 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 | |
| 604 | SCARA5/TGFBI ratio | PRORT001759 | 3.94 | Protein ratios | Hepatocyte | 10 | 3 | 6 | 12 | |
| 605 | BID levels | PROLV000195 | 3.93 | Protein levels | Myeloid | 15 | 3 | 7 | 16 | |
| 606 | Heme malignancy, Leukaemia | MALIG000042 | 3.93 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 607 | CD164 levels | PROLV000313 | 3.91 | Protein levels | Myeloid | 20 | 2 | 10 | 12 | |
| 608 | Wheeze | RESPI000034 | 3.89 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 609 | Lysine | METAB000026 | 3.89 | Metabolites | Hepatocyte | 1 | 2 | 7 | 16 | |
| 610 | AXIN1/DOK2 ratio | PRORT000168 | 3.87 | Protein ratios | Granulosa cell | 5 | 2 | 6 | 17 | |
| 611 | LAYN/ULBP2 ratio | PRORT001435 | 3.87 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 612 | ANXA10 levels | PROLV000105 | 3.87 | Protein levels | Myeloid | 9 | 0 | 4 | 4 | |
| 613 | Medication, antiglaucoma | OPHTH000014 | 3.85 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 614 | Grey matter volume | NIMAG000023 | 3.83 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 615 | C3 levels | PROLV000232 | 3.83 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 616 | ITM2A levels | PROLV001120 | 3.80 | Protein levels | Hepatocyte | 32 | 3 | 11 | 28 | |
| 617 | Medication, antipyretic | MISCL000035 | 3.80 | Miscellaneous | Lymphocyte | 0 | 3 | 10 | 20 | |
| 618 | LEPR/NRCAM ratio | PRORT001447 | 3.80 | Protein ratios | Epithelial | 23 | 1 | 13 | 18 | |
| 619 | Pregnancy complication, vomiting | REPRO000035 | 3.80 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 620 | NT5C1A levels | PROLV001439 | 3.79 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 621 | ATXN10/SLC27A4 ratio | PRORT000163 | 3.76 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 622 | Heart rate, exercise | CARDI000017 | 3.72 | Cardiac | Muscle / cardiac | 19 | 6 | 12 | 25 | |
| 623 | LDLR levels | PROLV001194 | 3.71 | Protein levels | Myeloid | 136 | 0 | 4 | 9 | |
| 624 | PPP1R2/USP8 ratio | PRORT001708 | 3.70 | Protein ratios | Hepatocyte | 13 | 3 | 9 | 21 | |
| 625 | GDI2 levels | PROLV000871 | 3.68 | Protein levels | Hepatocyte | 0 | 4 | 12 | 35 | |
| 626 | SNRPB2 levels | PROLV001910 | 3.68 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 627 | Coagulation disorder | HEMAT000017 | 3.67 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 628 | PTGR1 levels | PROLV001666 | 3.66 | Protein levels | Hepatocyte | 38 | 3 | 11 | 18 | |
| 629 | DCXR/KYNU ratio | PRORT000877 | 3.66 | Protein ratios | Hepatocyte | 13 | 3 | 10 | 15 | |
| 630 | Gut microbial abundance, Rubneribacter | GASTR000035 | 3.65 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 631 | FLT1/VEGFA ratio | PRORT001164 | 3.64 | Protein ratios | Muscle / cardiac | 9 | 2 | 6 | 11 | |
| 632 | CLEC1B/MPIG6B ratio | PRORT000644 | 3.64 | Protein ratios | Myeloid | 4 | 4 | 12 | 13 | |
| 633 | Family history, diabetes | METBL000009 | 3.62 | Metabolic | Hematopoietic progenitor | 0 | 1 | 1 | 5 | |
| 634 | CLTA levels | PROLV000466 | 3.62 | Protein levels | Myeloid | 7 | 6 | 11 | 16 | |
| 635 | Fatty acids unsaturation | LIPID000032 | 3.62 | Lipids | Hepatocyte | 1,087 | 2 | 7 | 16 | |
| 636 | TMEM106A levels | PROLV002046 | 3.62 | Protein levels | Myeloid | 96 | 3 | 13 | 19 | |
| 637 | Alanine | METAB000017 | 3.60 | Metabolites | Hepatocyte | 251 | 1 | 5 | 12 | |
| 638 | Systemic lupus erythematosus, SLE | IMMUN000020 | 3.60 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 639 | MNDA/NCF2 ratio | PRORT001550 | 3.60 | Protein ratios | Myeloid | 13 | 2 | 5 | 6 | |
| 640 | TNFRSF19 levels | PROLV002067 | 3.58 | Protein levels | Muscle / cardiac | 8 | 1 | 8 | 14 | |
| 641 | ITPR1 levels | PROLV001122 | 3.58 | Protein levels | Vascular | 20 | 3 | 13 | 25 | |
| 642 | Fatty acids ratio | LIPID000031 | 3.58 | Lipids | Hepatocyte | 426 | 2 | 8 | 18 | |
| 643 | AXIN1/ITGB1BP2 ratio | PRORT000173 | 3.56 | Protein ratios | Myeloid | 19 | 5 | 16 | 18 | |
| 644 | Fatty liver disease, nonalcoholic overweight | HPBIL000030 | 3.55 | Hepatopancreatobiliary | Neural / glial | 1 | 0 | 3 | 9 | |
| 645 | OXCT1 levels | PROLV001479 | 3.55 | Protein levels | Myeloid | 26 | 3 | 10 | 10 | |
| 646 | CRYBB1 levels | PROLV000532 | 3.55 | Protein levels | Lymphocyte | 15 | 5 | 12 | 33 | |
| 647 | ATG4A levels | PROLV000159 | 3.55 | Protein levels | Vascular | 0 | 3 | 11 | 31 | |
| 648 | PON2 levels | PROLV001601 | 3.53 | Protein levels | Hepatocyte | 91 | 2 | 9 | 17 | |
| 649 | Consultant specialty, urology | MISCL000020 | 3.52 | Miscellaneous | Neural / glial | 3 | 0 | 8 | 6 | |
| 650 | CCL22 levels | PROLV000289 | 3.51 | Protein levels | Myeloid | 15 | 2 | 8 | 17 | |
| 651 | PODXL2/SDC1 ratio | PRORT001696 | 3.48 | Protein ratios | Hepatocyte | 33 | 2 | 8 | 13 | |
| 652 | CDH5 levels | PROLV000376 | 3.47 | Protein levels | Vascular | 33 | 3 | 9 | 25 | |
| 653 | Benign neoplasm, Salivary gland | MALIG000006 | 3.47 | Malignancy | Neural / glial | 1 | 1 | 4 | 11 | |
| 654 | BCR/DECR1 ratio | PRORT000223 | 3.46 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 31 | |
| 655 | CCL8 levels | PROLV000300 | 3.45 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 656 | SSC5D levels | PROLV001948 | 3.45 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 657 | Pneumonia | IMMUN000069 | 3.45 | Immunologic | Hepatocyte | 27 | 1 | 4 | 13 | |
| 658 | METAP2/USP8 ratio | PRORT001526 | 3.44 | Protein ratios | Hepatocyte | 0 | 2 | 3 | 11 | |
| 659 | Iron deficiency anaemia | HEMAT000011 | 3.44 | Hematologic | Hepatocyte | 16 | 1 | 3 | 9 | |
| 660 | CD99 levels | PROLV000363 | 3.43 | Protein levels | Granulosa cell | 27 | 1 | 7 | 9 | |
| 661 | GAL levels | PROLV000847 | 3.40 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 662 | Gut microbial abundance, Holdemania | GASTR000026 | 3.40 | Gastrointestinal | Hepatocyte | 0 | 3 | 13 | 24 | |
| 663 | TBCB/TBCC ratio | PRORT001827 | 3.39 | Protein ratios | Myeloid | 1 | 2 | 10 | 23 | |
| 664 | CACNA2D3 levels | PROLV000250 | 3.39 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 665 | CD84/SORT1 ratio | PRORT000528 | 3.38 | Protein ratios | Myeloid | 44 | 2 | 10 | 15 | |
| 666 | ADAMTS8/FAP ratio | PRORT000026 | 3.38 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 667 | LSP1 levels | PROLV001238 | 3.37 | Protein levels | Neural / glial | 14 | 6 | 14 | 47 | |
| 668 | HGF/MMP8 ratio | PRORT001282 | 3.36 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 19 | |
| 669 | YBX1 levels | PROLV002204 | 3.36 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 25 | |
| 670 | Radiotherapy | MALIG000049 | 3.35 | Malignancy | Muscle / cardiac | 0 | 3 | 10 | 19 | |
| 671 | Bacterial intestinal infection | IMMUN000052 | 3.35 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 672 | MESD/NCK2 ratio | PRORT001516 | 3.34 | Protein ratios | Neural / glial | 8 | 4 | 10 | 17 | |
| 673 | IL1B levels | PROLV001059 | 3.33 | Protein levels | Myeloid | 2 | 3 | 11 | 18 | |
| 674 | Infant mortality rate | MISCL000003 | 3.31 | Miscellaneous | Myeloid | 1 | 3 | 10 | 20 | |
| 675 | Benign neoplasm, Ocular | MALIG000005 | 3.27 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 676 | PLA2G15 levels | PROLV001566 | 3.26 | Protein levels | Myeloid | 214 | 2 | 9 | 10 | |
| 677 | FST levels | PROLV000829 | 3.26 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 678 | PRND levels | PROLV001636 | 3.25 | Protein levels | Vascular | 49 | 4 | 10 | 21 | |
| 679 | IL22RA2 levels | PROLV001067 | 3.25 | Protein levels | Myeloid | 0 | 2 | 13 | 12 | |
| 680 | CRADD/FADD ratio | PRORT000745 | 3.23 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 7 | |
| 681 | Barrett's oesophagus | GASTR000046 | 3.22 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 682 | TNFSF11 levels | PROLV002076 | 3.22 | Protein levels | Hepatocyte | 28 | 3 | 10 | 14 | |
| 683 | Ketone bodies | METAB000056 | 3.22 | Metabolites | Hepatocyte | 118 | 1 | 6 | 7 | |
| 684 | RSPO1/RSPO3 ratio | PRORT001750 | 3.21 | Protein ratios | Myeloid | 5 | 4 | 6 | 14 | |
| 685 | BACH1/CD2AP ratio | PRORT000191 | 3.20 | Protein ratios | Hepatocyte | 17 | 2 | 14 | 35 | |
| 686 | Cancer, Liver | MALIG000018 | 3.20 | Malignancy | Hepatocyte | 15 | 1 | 6 | 17 | |
| 687 | Metabolon metabolite | METAB000076 | 3.20 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 688 | ABO levels | PROLV000007 | 3.18 | Protein levels | Muscle / cardiac | 5 | 1 | 6 | 10 | |
| 689 | CEACAM1/GGT1 ratio | PRORT000586 | 3.18 | Protein ratios | Hepatocyte | 33 | 1 | 4 | 9 | |
| 690 | DKK4/REG1A ratio | PRORT000909 | 3.12 | Protein ratios | Hepatocyte | 32 | 2 | 8 | 16 | |
| 691 | PADI4 levels | PROLV001484 | 3.11 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 692 | CHMP6 levels | PROLV000432 | 3.11 | Protein levels | Stromal / connective | 7 | 4 | 6 | 19 | |
| 693 | Anorexia nervosa | PSYCH000011 | 3.11 | Psychiatric | Myeloid | 0 | 1 | 8 | 7 | |
| 694 | ECG morphology, unadjusted | ECGRM000002 | 3.08 | Electrocardiogram | Muscle / cardiac | 478 | 2 | 4 | 6 | |
| 695 | Skin and soft tissue infection | IMMUN000073 | 3.08 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 696 | Taurine metabolites | METAB000014 | 3.06 | Metabolites | Vascular | 8 | 0 | 1 | 1 | |
| 697 | CNTN3 levels | PROLV000477 | 3.05 | Protein levels | Hepatocyte | 99 | 4 | 9 | 30 | |
| 698 | ENTPD2 levels | PROLV000712 | 3.04 | Protein levels | Hepatocyte | 48 | 1 | 4 | 10 | |
| 699 | GSTT2B levels | PROLV000943 | 3.01 | Protein levels | Muscle / cardiac | 20 | 2 | 5 | 11 | |
| 700 | SLA2 levels | PROLV001874 | 3.01 | Protein levels | Stromal / connective | 21 | 4 | 5 | 9 | |
| 701 | KYNU/SCLY ratio | PRORT001416 | 3.01 | Protein ratios | Hepatocyte | 7 | 4 | 16 | 39 | |
| 702 | Influenza | IMMUN000065 | 3.00 | Immunologic | B / plasma cell | 21 | 3 | 6 | 11 | |
| 703 | Oedema | MISCL000012 | 3.00 | Miscellaneous | Lymphocyte | 13 | 2 | 8 | 38 | |
| 704 | BLVRB/CA3 ratio | PRORT000240 | 2.99 | Protein ratios | Myeloid | 2 | 4 | 11 | 22 | |
| 705 | Insulin levels | METBL000040 | 2.98 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 706 | Fibroblastic disorder | MSKEL000064 | 2.98 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 707 | Implantable cardioverter-defibrillator | CARDI000050 | 2.98 | Cardiac | Muscle / cardiac | 18 | 2 | 5 | 10 | |
| 708 | Pregnancy complication, haemorrhage | REPRO000030 | 2.97 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 709 | ENG levels | PROLV000704 | 2.97 | Protein levels | Adipose | 10 | 4 | 12 | 30 | |
| 710 | Creatinine | NEPHR000018 | 2.96 | Nephrourologic | Hepatocyte | 2,903 | 2 | 6 | 8 | |
| 711 | Diabetes, secondary | METBL000032 | 2.95 | Metabolic | Neural / glial | 0 | 2 | 10 | 24 | |
| 712 | NMT1 levels | PROLV001412 | 2.95 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 713 | NPC2 levels | PROLV001419 | 2.94 | Protein levels | Myeloid | 24 | 1 | 5 | 9 | |
| 714 | Heme malignancy, Myeloid | MALIG000045 | 2.94 | Malignancy | Hepatocyte | 0 | 1 | 6 | 15 | |
| 715 | SIL1 levels | PROLV001866 | 2.94 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 716 | Iris and ciliary body disorder | OPHTH000005 | 2.94 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 717 | CASP1 levels | PROLV000265 | 2.92 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 718 | Nephritis | NEPHR000024 | 2.90 | Nephrourologic | Hepatocyte | 24 | 0 | 5 | 9 | |
| 719 | GMFG levels | PROLV000901 | 2.90 | Protein levels | Myeloid | 17 | 4 | 9 | 23 | |
| 720 | Shift work | SOCIO000008 | 2.88 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 721 | PLXNB2/SEMA7A ratio | PRORT001690 | 2.88 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 21 | |
| 722 | Dementia | NEURO000019 | 2.88 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 723 | CALCOCO1/CRACR2A ratio | PRORT000293 | 2.86 | Protein ratios | Muscle / cardiac | 0 | 1 | 19 | 32 | |
| 724 | Sexually transmitted infection | IMMUN000072 | 2.86 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 725 | FKBP5/MITD1 ratio | PRORT001158 | 2.83 | Protein ratios | Hepatocyte | 8 | 1 | 8 | 7 | |
| 726 | SIRT2/STAT5B ratio | PRORT001787 | 2.83 | Protein ratios | Hepatocyte | 8 | 2 | 7 | 17 | |
| 727 | SCPEP1 levels | PROLV001792 | 2.83 | Protein levels | Muscle / cardiac | 13 | 2 | 6 | 16 | |
| 728 | ECG-predicted BMI discrepancy | BMORP000008 | 2.83 | Body morphology | Muscle / cardiac | 0 | 2 | 5 | 20 | |
| 729 | GIPC2 levels | PROLV000888 | 2.82 | Protein levels | Hepatocyte | 4 | 2 | 5 | 11 | |
| 730 | CA1/HMBS ratio | PRORT000269 | 2.82 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 731 | DNM3 levels | PROLV000639 | 2.81 | Protein levels | Hematopoietic progenitor | 17 | 1 | 2 | 10 | |
| 732 | CCL2 levels | PROLV000286 | 2.81 | Protein levels | Myeloid | 106 | 3 | 6 | 7 | |
| 733 | ECG morphology, adjusted | ECGRM000001 | 2.81 | Electrocardiogram | Muscle / cardiac | 426 | 2 | 3 | 9 | |
| 734 | Mammary dysplasia | BREAS000001 | 2.79 | Breast | Adipose | 0 | 1 | 8 | 17 | |
| 735 | Cholesteryl esters, HDL | LIPID000015 | 2.78 | Lipids | Hepatocyte | 2,085 | 3 | 9 | 17 | |
| 736 | FAM172A levels | PROLV000762 | 2.78 | Protein levels | Stromal / connective | 9 | 2 | 9 | 24 | |
| 737 | Sputum production | RESPI000033 | 2.78 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 738 | FOLH1 levels | PROLV000821 | 2.78 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 739 | EFEMP1 levels | PROLV000679 | 2.78 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 740 | Acylcarnitines | METAB000038 | 2.78 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 741 | PCBP2 levels | PROLV001503 | 2.77 | Protein levels | Lymphocyte | 33 | 4 | 11 | 19 | |
| 742 | White matter microstructure | NIMAG000013 | 2.77 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 743 | SLC4A1 levels | PROLV001882 | 2.76 | Protein levels | Lymphocyte | 0 | 3 | 7 | 28 | |
| 744 | Maximal oxygen uptake | CARDI000026 | 2.76 | Cardiac | B / plasma cell | 1 | 4 | 12 | 22 | |
| 745 | Pneumonopathy | RESPI000016 | 2.75 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 746 | PDLIM5 levels | PROLV001528 | 2.75 | Protein levels | Stromal / connective | 1 | 3 | 13 | 30 | |
| 747 | DECR1/METAP1D ratio | PRORT000883 | 2.74 | Protein ratios | Muscle / cardiac | 0 | 1 | 5 | 13 | |
| 748 | FUT3 levels | PROLV000837 | 2.74 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 749 | DPP6/SEZ6L2 ratio | PRORT000948 | 2.72 | Protein ratios | Myeloid | 37 | 4 | 14 | 16 | |
| 750 | COMP/THBS4 ratio | PRORT000714 | 2.72 | Protein ratios | Neural / glial | 1 | 5 | 15 | 26 | |
| 751 | CDKN1A/TBL1X ratio | PRORT000573 | 2.72 | Protein ratios | Hepatocyte | 13 | 3 | 13 | 13 | |
| 752 | Phosphatidylglycerols | LIPID000060 | 2.71 | Lipids | Granulosa cell | 3 | 3 | 10 | 22 | |
| 753 | ARTN levels | PROLV000148 | 2.71 | Protein levels | Myeloid | 0 | 3 | 10 | 18 | |
| 754 | CXCL12/TIMP3 ratio | PRORT000821 | 2.70 | Protein ratios | Vascular | 21 | 2 | 6 | 10 | |
| 755 | GPKOW/PXN ratio | PRORT001239 | 2.70 | Protein ratios | Myeloid | 0 | 1 | 5 | 9 | |
| 756 | Brainstem volume | NIMAG000017 | 2.68 | Neuroimaging | Neural / glial | 10 | 3 | 5 | 15 | |
| 757 | Childhood maltreatment | PSYCH000052 | 2.68 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 758 | Family history, coronary artery disease | VASCU000021 | 2.68 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 759 | Arterial dissection | VASCU000003 | 2.68 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 760 | Pregnancy complication, ectopic | REPRO000028 | 2.67 | Reproductive | Vascular | 1 | 1 | 11 | 28 | |
| 761 | Gastric ulcer | GASTR000048 | 2.66 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 762 | PCDH9 levels | PROLV001508 | 2.66 | Protein levels | Myeloid | 32 | 2 | 9 | 15 | |
| 763 | Perivascular space burden | NIMAG000011 | 2.66 | Neuroimaging | Muscle / cardiac | 3 | 2 | 5 | 7 | |
| 764 | BCL2L15 levels | PROLV000188 | 2.65 | Protein levels | B / plasma cell | 9 | 5 | 9 | 29 | |
| 765 | Lysophosphatidylcholines | LIPID000054 | 2.65 | Lipids | Neural / glial | 26 | 2 | 4 | 15 | |
| 766 | GP1BA/SIAE ratio | PRORT001228 | 2.64 | Protein ratios | Myeloid | 2 | 3 | 14 | 22 | |
| 767 | MMP8/PGLYRP1 ratio | PRORT001544 | 2.62 | Protein ratios | Myeloid | 15 | 5 | 9 | 13 | |
| 768 | Glutamine | METAB000021 | 2.62 | Metabolites | Hepatocyte | 401 | 2 | 9 | 18 | |
| 769 | FABP4 levels | PROLV000754 | 2.62 | Protein levels | Stromal / connective | 8 | 0 | 3 | 6 | |
| 770 | AK1/NSFL1C ratio | PRORT000062 | 2.62 | Protein ratios | Hepatocyte | 0 | 2 | 5 | 21 | |
| 771 | TEX101 levels | PROLV002010 | 2.60 | Protein levels | Pancreatic epithelium | 0 | 0 | 5 | 7 | |
| 772 | Atrophic skin disorder | DERMA000037 | 2.60 | Dermatologic | Lymphocyte | 12 | 2 | 8 | 14 | |
| 773 | Thigh muscle volume | BMORP000020 | 2.59 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 774 | TAX1BP3 levels | PROLV001995 | 2.58 | Protein levels | Myeloid | 0 | 2 | 5 | 6 | |
| 775 | Gut microbial abundance, Olsenella C | GASTR000030 | 2.58 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 776 | Short-chain fatty acids | METAB000053 | 2.58 | Metabolites | Granulosa cell | 20 | 5 | 12 | 17 | |
| 777 | PDGFRB levels | PROLV001526 | 2.57 | Protein levels | Myeloid | 59 | 6 | 15 | 28 | |
| 778 | ADAMTS15/CLMP ratio | PRORT000024 | 2.57 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 13 | |
| 779 | METAP1D levels | PROLV001303 | 2.57 | Protein levels | Myeloid | 4 | 4 | 7 | 16 | |
| 780 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 2.56 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 781 | HSPG2 levels | PROLV000999 | 2.56 | Protein levels | Adipose | 16 | 2 | 5 | 13 | |
| 782 | CKAP4/LTBR ratio | PRORT000622 | 2.55 | Protein ratios | Muscle / cardiac | 17 | 1 | 6 | 18 | |
| 783 | NTPROBNP levels | PROLV001446 | 2.55 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 784 | Phosphatidylcholines | LIPID000058 | 2.55 | Lipids | Hepatocyte | 408 | 1 | 3 | 17 | |
| 785 | Brain MRI signal intensity | NIMAG000003 | 2.54 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 786 | DLL1/TGFBR2 ratio | PRORT000919 | 2.52 | Protein ratios | Vascular | 20 | 0 | 3 | 2 | |
| 787 | GBP2 levels | PROLV000861 | 2.52 | Protein levels | Myeloid | 0 | 2 | 11 | 16 | |
| 788 | Medication, macular degeneration | OPHTH000015 | 2.51 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 789 | Medication, anti-gout | METBL000025 | 2.51 | Metabolic | Hepatocyte | 167 | 1 | 4 | 9 | |
| 790 | EIF4EBP1 levels | PROLV000697 | 2.50 | Protein levels | Muscle / cardiac | 5 | 3 | 9 | 20 | |
| 791 | GOLM2 levels | PROLV000909 | 2.49 | Protein levels | Myeloid | 155 | 2 | 9 | 8 | |
| 792 | GLT25D1 levels | PROLV000899 | 2.49 | Protein levels | Vascular | 0 | 1 | 4 | 5 | |
| 793 | SHISA5 levels | PROLV001856 | 2.48 | Protein levels | Myeloid | 6 | 1 | 3 | 7 | |
| 794 | Isoleucine | METAB000024 | 2.48 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 795 | Pancreas volume | HPBIL000029 | 2.47 | Hepatopancreatobiliary | Pancreatic epithelium | 12 | 0 | 4 | 7 | |
| 796 | ADAM23 levels | PROLV000028 | 2.47 | Protein levels | Granulosa cell | 35 | 1 | 4 | 4 | |
| 797 | PSMG3 levels | PROLV001660 | 2.46 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 798 | Bundle branch block | CARDI000029 | 2.45 | Cardiac | Muscle / cardiac | 13 | 3 | 6 | 11 | |
| 799 | FURIN/PLA2G15 ratio | PRORT001185 | 2.45 | Protein ratios | Adipose | 9 | 2 | 8 | 18 | |
| 800 | Ventricular function | CARDI000008 | 2.45 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 801 | Other ear disorder | AUDIO000004 | 2.45 | Auditory | Epithelial | 6 | 0 | 7 | 9 | |
| 802 | CLEC1A/TNFRSF1A ratio | PRORT000632 | 2.45 | Protein ratios | Vascular | 6 | 5 | 14 | 19 | |
| 803 | IGSF9 levels | PROLV001040 | 2.45 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 804 | Pulmonary fibrosis | RESPI000017 | 2.45 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 805 | Hypercalcaemia | METBL000005 | 2.44 | Metabolic | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 806 | Delivery | REPRO000004 | 2.43 | Reproductive | Myeloid | 0 | 2 | 5 | 10 | |
| 807 | VPS4B levels | PROLV002167 | 2.43 | Protein levels | Stromal / connective | 9 | 4 | 8 | 15 | |
| 808 | Family history, hypertension | VASCU000022 | 2.42 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 809 | Cancer, Oesophagus | MALIG000021 | 2.42 | Malignancy | Salivary epithelium | 1 | 0 | 2 | 4 | |
| 810 | Excessive sweating | DERMA000029 | 2.42 | Dermatologic | Myeloid | 4 | 1 | 3 | 3 | |
| 811 | Pancreatitis | HPBIL000027 | 2.42 | Hepatopancreatobiliary | Hepatocyte | 57 | 0 | 1 | 7 | |
| 812 | RRM2B levels | PROLV001757 | 2.41 | Protein levels | Myeloid | 1 | 3 | 8 | 10 | |
| 813 | Exotropia | OPHTH000022 | 2.41 | Ophthalmic | Myeloid | 6 | 1 | 8 | 7 | |
| 814 | GCG levels | PROLV000866 | 2.40 | Protein levels | Hepatocyte | 66 | 1 | 7 | 13 | |
| 815 | Gestational hypertension | VASCU000045 | 2.40 | Vascular | Lymphocyte | 3 | 1 | 7 | 22 | |
| 816 | IMPACT levels | PROLV001085 | 2.40 | Protein levels | Muscle / cardiac | 1 | 5 | 11 | 38 | |
| 817 | Benign neoplasm, Endocrine | MALIG000003 | 2.40 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 818 | FABP2 levels | PROLV000752 | 2.38 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 819 | CES3 levels | PROLV000407 | 2.37 | Protein levels | Hepatocyte | 70 | 1 | 6 | 12 | |
| 820 | Chondrocalcinosis | MSKEL000014 | 2.37 | Musculoskeletal | Vascular | 0 | 1 | 6 | 12 | |
| 821 | COVID-19 | IMMUN000054 | 2.37 | Immunologic | Lymphocyte | 1 | 1 | 12 | 37 | |
| 822 | Pyrimidine metabolites | METAB000063 | 2.36 | Metabolites | Granulosa cell | 0 | 1 | 7 | 16 | |
| 823 | Alport syndrome | NEPHR000003 | 2.35 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 824 | BPIFB2 levels | PROLV000211 | 2.34 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 825 | Drug hypersensitivity | IMMUN000006 | 2.33 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 826 | Cholesterol, HDL | LIPID000003 | 2.33 | Lipids | Hepatocyte | 4,625 | 3 | 8 | 17 | |
| 827 | Heart rate response to exercise | CARDI000025 | 2.33 | Cardiac | Vascular | 12 | 0 | 6 | 5 | |
| 828 | SPTLC1 levels | PROLV001941 | 2.33 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 829 | Spermatocele | REPRO000014 | 2.32 | Reproductive | Epithelial | 8 | 0 | 5 | 12 | |
| 830 | PLAT levels | PROLV001571 | 2.32 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 831 | TMSB10/ZBTB16 ratio | PRORT001842 | 2.31 | Protein ratios | Muscle / cardiac | 29 | 4 | 8 | 25 | |
| 832 | IGLL1 levels | PROLV001036 | 2.30 | Protein levels | Muscle / cardiac | 0 | 3 | 8 | 20 | |
| 833 | DPP7 levels | PROLV000648 | 2.30 | Protein levels | Muscle / cardiac | 129 | 4 | 14 | 27 | |
| 834 | Hernia | GASTR000008 | 2.28 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 835 | RNASE6 levels | PROLV001740 | 2.26 | Protein levels | Myeloid | 66 | 2 | 5 | 13 | |
| 836 | Benign neoplasm, Melanocytic | MALIG000004 | 2.26 | Malignancy | Stromal / connective | 2 | 0 | 0 | 5 | |
| 837 | Oral health conditions, none | DENTA000009 | 2.25 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 838 | Peripheral artery disease | VASCU000042 | 2.25 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 839 | MENT levels | PROLV001296 | 2.25 | Protein levels | Hepatocyte | 57 | 2 | 10 | 14 | |
| 840 | EDAR/IRAK4 ratio | PRORT000971 | 2.24 | Protein ratios | Myeloid | 38 | 2 | 13 | 16 | |
| 841 | PTPRN2 levels | PROLV001679 | 2.23 | Protein levels | Pancreatic epithelium | 1 | 0 | 3 | 3 | |
| 842 | PDGFB levels | PROLV001523 | 2.23 | Protein levels | Myeloid | 60 | 3 | 12 | 14 | |
| 843 | CD40LG/SERPINE1 ratio | PRORT000453 | 2.23 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 844 | BLVRB/CA2 ratio | PRORT000239 | 2.22 | Protein ratios | Vascular | 0 | 0 | 7 | 11 | |
| 845 | PDGFB/TIMP3 ratio | PRORT001648 | 2.22 | Protein ratios | Hepatocyte | 15 | 1 | 8 | 25 | |
| 846 | Hippocampal volume | NIMAG000024 | 2.22 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 847 | Bile acid levels | HPBIL000016 | 2.21 | Hepatopancreatobiliary | Hepatocyte | 12 | 1 | 5 | 10 | |
| 848 | CXCL3/CXCL5 ratio | PRORT000825 | 2.20 | Protein ratios | Myeloid | 8 | 3 | 14 | 24 | |
| 849 | SLC9A3R2 levels | PROLV001886 | 2.20 | Protein levels | Vascular | 16 | 2 | 7 | 14 | |
| 850 | Immune cell marker, pDC | HEMAT000028 | 2.20 | Hematologic | Myeloid | 0 | 3 | 12 | 14 | |
| 851 | Cholesteryl esters | LIPID000019 | 2.19 | Lipids | Neural / glial | 42 | 2 | 4 | 15 | |
| 852 | Ceramides | LIPID000065 | 2.19 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 853 | LTBR levels | PROLV001244 | 2.19 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 854 | NOTCH1/TIE1 ratio | PRORT001592 | 2.19 | Protein ratios | Neural / glial | 13 | 3 | 9 | 15 | |
| 855 | DNAJC6 levels | PROLV000635 | 2.18 | Protein levels | Hematopoietic progenitor | 9 | 5 | 7 | 15 | |
| 856 | Brugada syndrome | CARDI000020 | 2.18 | Cardiac | Muscle / cardiac | 27 | 4 | 6 | 7 | |
| 857 | PDGFB/SPARC ratio | PRORT001645 | 2.17 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 858 | Tryptophan metabolites | METAB000015 | 2.17 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 859 | MYCT1 levels | PROLV001357 | 2.17 | Protein levels | B / plasma cell | 0 | 2 | 6 | 23 | |
| 860 | Kidney cyst | NEPHR000004 | 2.16 | Nephrourologic | Stromal / connective | 12 | 1 | 6 | 13 | |
| 861 | IBD-Ulcerative colitis, with PSC | IMMUN000016 | 2.16 | Immunologic | Myeloid | 38 | 5 | 13 | 25 | |
| 862 | JAM2/TNFRSF14 ratio | PRORT001399 | 2.16 | Protein ratios | Platelet | 2 | 6 | 12 | 25 | |
| 863 | CA1/CA3 ratio | PRORT000268 | 2.15 | Protein ratios | B / plasma cell | 1 | 5 | 16 | 23 | |
| 864 | FSTL1 levels | PROLV000830 | 2.15 | Protein levels | Myeloid | 71 | 2 | 8 | 15 | |
| 865 | PDGFB/ST6GAL1 ratio | PRORT001647 | 2.15 | Protein ratios | Neural / glial | 12 | 6 | 11 | 24 | |
| 866 | BTN3A2 levels | PROLV000220 | 2.15 | Protein levels | Lymphocyte | 122 | 3 | 11 | 23 | |
| 867 | PSAPL1 levels | PROLV001654 | 2.14 | Protein levels | Cutaneous epithelium | 66 | 0 | 14 | 13 | |
| 868 | Cancer, Breast | MALIG000011 | 2.13 | Malignancy | Cutaneous epithelium | 47 | 1 | 8 | 13 | |
| 869 | FGD3 levels | PROLV000792 | 2.13 | Protein levels | Platelet | 25 | 4 | 8 | 18 | |
| 870 | Osteoarthritis, OA | MSKEL000012 | 2.13 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 871 | POLR2F levels | PROLV001598 | 2.13 | Protein levels | Muscle / cardiac | 1 | 4 | 8 | 22 | |
| 872 | Tyrosine metabolites | METAB000016 | 2.13 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 873 | CCN2/HBEGF ratio | PRORT000365 | 2.12 | Protein ratios | Myeloid | 66 | 3 | 14 | 13 | |
| 874 | Gynaecomastia | BREAS000003 | 2.11 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 875 | Connective tissue disorder | MSKEL000060 | 2.11 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 876 | Osteopenia | MSKEL000009 | 2.10 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 877 | Breast disorder | BREAS000002 | 2.10 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 878 | Arterial stiffness | VASCU000050 | 2.10 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 879 | TNFRSF11B levels | PROLV002061 | 2.10 | Protein levels | Hepatocyte | 94 | 1 | 6 | 16 | |
| 880 | Organic acid metabolites | METAB000067 | 2.10 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 881 | COL3A1 levels | PROLV000489 | 2.09 | Protein levels | Myeloid | 15 | 4 | 10 | 22 | |
| 882 | CPXM1/VEGFC ratio | PRORT000737 | 2.09 | Protein ratios | Hematopoietic progenitor | 21 | 2 | 3 | 15 | |
| 883 | CNTN1 levels | PROLV000475 | 2.09 | Protein levels | Stromal / connective | 121 | 4 | 10 | 25 | |
| 884 | Cholesterol, HDL free | LIPID000001 | 2.08 | Lipids | Hepatocyte | 1,923 | 3 | 8 | 19 | |
| 885 | Phospholipids, HDL | LIPID000048 | 2.07 | Lipids | Hepatocyte | 2,061 | 3 | 9 | 16 | |
| 886 | Skin sebum | DERMA000036 | 2.07 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 887 | Biliary atresia | HPBIL000002 | 2.07 | Hepatopancreatobiliary | Stromal / connective | 0 | 2 | 8 | 6 | |
| 888 | CXCL5/EDAR ratio | PRORT000827 | 2.06 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 889 | FETUB levels | PROLV000790 | 2.06 | Protein levels | Hepatocyte | 44 | 1 | 7 | 7 | |
| 890 | L3HYPDH levels | PROLV001172 | 2.06 | Protein levels | Myeloid | 37 | 4 | 8 | 12 | |
| 891 | EIF4G1/PLA2G4A ratio | PRORT001013 | 2.06 | Protein ratios | Vascular | 11 | 2 | 10 | 16 | |
| 892 | CASP3/LYN ratio | PRORT000314 | 2.05 | Protein ratios | Myeloid | 1 | 2 | 14 | 44 | |
| 893 | THOP1 levels | PROLV002028 | 2.05 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 894 | Medication, calcium channel blocker | VASCU000035 | 2.05 | Vascular | Vascular | 18 | 1 | 4 | 14 | |
| 895 | CD84/DAG1 ratio | PRORT000521 | 2.04 | Protein ratios | Muscle / cardiac | 12 | 3 | 10 | 18 | |
| 896 | SNAP25 levels | PROLV001906 | 2.03 | Protein levels | Muscle / cardiac | 18 | 1 | 5 | 11 | |
| 897 | F13B levels | PROLV000744 | 2.02 | Protein levels | Myeloid | 36 | 3 | 14 | 18 | |
| 898 | Nucleoside metabolites | METAB000061 | 2.02 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 899 | Leucine | METAB000025 | 2.02 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 900 | CSNK1G2 levels | PROLV000543 | 2.02 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 9 | |
| 901 | USP8/WASF1 ratio | PRORT001858 | 2.01 | Protein ratios | Myeloid | 1 | 3 | 8 | 12 | |
| 902 | SERPINA7 levels | PROLV001821 | 2.01 | Protein levels | Hepatocyte | 6 | 3 | 13 | 17 | |
| 903 | Pregnancy complication, obstructed labour | REPRO000031 | 2.01 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 904 | COL6A3/NBL1 ratio | PRORT000698 | 2.01 | Protein ratios | Stromal / connective | 29 | 2 | 2 | 8 | |
| 905 | Consultant specialty, general surgery | MISCL000017 | 2.01 | Miscellaneous | Neural / glial | 3 | 2 | 4 | 10 | |
| 906 | Blood pressure, BP, arterial | VASCU000007 | 2.00 | Vascular | Vascular | 603 | 3 | 7 | 9 | |
| 907 | Phosphatidylethanolamines | LIPID000059 | 2.00 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 908 | GP1BA levels | PROLV000913 | 1.99 | Protein levels | Myeloid | 60 | 5 | 12 | 17 | |
| 909 | CFH levels | PROLV000413 | 1.99 | Protein levels | Stromal / connective | 20 | 4 | 12 | 18 | |
| 910 | APOC1 levels | PROLV000122 | 1.98 | Protein levels | Myeloid | 58 | 2 | 13 | 19 | |
| 911 | DAG1 levels | PROLV000592 | 1.97 | Protein levels | Lymphocyte | 4 | 4 | 10 | 23 | |
| 912 | Nutritional and metabolic symptoms | METBL000016 | 1.97 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 913 | Brain neuroimaging quality metric | NIMAG000006 | 1.97 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 914 | SSNA1 levels | PROLV001950 | 1.96 | Protein levels | Platelet | 5 | 7 | 14 | 25 | |
| 915 | Tryptophan | METAB000030 | 1.96 | Metabolites | Hepatocyte | 4 | 2 | 6 | 16 | |
| 916 | CRKL/SERPINB1 ratio | PRORT000767 | 1.96 | Protein ratios | Myeloid | 1 | 5 | 15 | 18 | |
| 917 | Ovarian cyst | REPRO000022 | 1.96 | Reproductive | Pancreatic epithelium | 32 | 0 | 5 | 7 | |
| 918 | EZR levels | PROLV000739 | 1.96 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 919 | ATOX1 levels | PROLV000160 | 1.95 | Protein levels | Myeloid | 25 | 5 | 9 | 20 | |
| 920 | COL18A1/RARRES2 ratio | PRORT000691 | 1.95 | Protein ratios | Myeloid | 30 | 2 | 7 | 12 | |
| 921 | IL6ST/LEPR ratio | PRORT001353 | 1.94 | Protein ratios | Hepatocyte | 42 | 3 | 10 | 13 | |
| 922 | CEP43/MPHOSPH8 ratio | PRORT000599 | 1.94 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 923 | AMBP/EFEMP1 ratio | PRORT000085 | 1.94 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 11 | |
| 924 | SWAP70 levels | PROLV001983 | 1.94 | Protein levels | Hepatocyte | 3 | 2 | 9 | 12 | |
| 925 | Lactose intolerance | METBL000003 | 1.94 | Metabolic | Renal epithelium | 0 | 0 | 7 | 4 | |
| 926 | FKBP1B levels | PROLV000808 | 1.93 | Protein levels | Lymphocyte | 2 | 3 | 9 | 27 | |
| 927 | CDHR2 levels | PROLV000379 | 1.93 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 928 | AGRN levels | PROLV000057 | 1.93 | Protein levels | Stromal / connective | 53 | 0 | 2 | 8 | |
| 929 | ECG QRS-T angle | CARDI000033 | 1.93 | Cardiac | Muscle / cardiac | 57 | 2 | 4 | 10 | |
| 930 | HGS levels | PROLV000967 | 1.93 | Protein levels | Stromal / connective | 0 | 3 | 11 | 17 | |
| 931 | Corneal disorder | OPHTH000003 | 1.92 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 932 | RBM17 levels | PROLV001710 | 1.92 | Protein levels | Vascular | 9 | 0 | 3 | 10 | |
| 933 | TP53I3 levels | PROLV002091 | 1.91 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 934 | GP1BB levels | PROLV000914 | 1.91 | Protein levels | Lymphocyte | 14 | 3 | 6 | 18 | |
| 935 | AKT2 levels | PROLV000075 | 1.90 | Protein levels | Stromal / connective | 6 | 3 | 10 | 21 | |
| 936 | Bleeding gums | DENTA000011 | 1.90 | Dental | Lymphocyte | 0 | 0 | 12 | 15 | |
| 937 | Lipoprotein particles, HDL | LIPID000043 | 1.89 | Lipids | Hepatocyte | 1,830 | 3 | 8 | 19 | |
| 938 | GRN levels | PROLV000933 | 1.89 | Protein levels | Myeloid | 36 | 1 | 4 | 9 | |
| 939 | MCEMP1 levels | PROLV001285 | 1.89 | Protein levels | Myeloid | 46 | 3 | 8 | 17 | |
| 940 | Implant | MISCL000025 | 1.88 | Miscellaneous | Stromal / connective | 0 | 0 | 0 | 0 | |
| 941 | Birth complication | REPRO000036 | 1.87 | Reproductive | Muscle / cardiac | 0 | 0 | 7 | 16 | |
| 942 | DNER levels | PROLV000637 | 1.86 | Protein levels | Vascular | 69 | 1 | 6 | 18 | |
| 943 | WAS levels | PROLV002184 | 1.86 | Protein levels | Hepatocyte | 25 | 2 | 6 | 11 | |
| 944 | INPP5J levels | PROLV001090 | 1.86 | Protein levels | B / plasma cell | 8 | 1 | 7 | 21 | |
| 945 | AGRN/HSPG2 ratio | PRORT000048 | 1.86 | Protein ratios | Stromal / connective | 22 | 7 | 7 | 25 | |
| 946 | TBCC/WWP2 ratio | PRORT001828 | 1.85 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 15 | |
| 947 | Cerebral aneurysm | VASCU000004 | 1.84 | Vascular | Vascular | 0 | 0 | 1 | 5 | |
| 948 | GPIHBP1 levels | PROLV000924 | 1.84 | Protein levels | Granulosa cell | 39 | 1 | 6 | 8 | |
| 949 | Hypothyroidism, acquired | ENDOC000012 | 1.84 | Endocrine | Hepatocyte | 1 | 4 | 11 | 37 | |
| 950 | Carbohydrate metabolites | METAB000035 | 1.83 | Metabolites | Hepatocyte | 7 | 2 | 13 | 22 | |
| 951 | SSC4D/TNFSF10 ratio | PRORT001816 | 1.83 | Protein ratios | Hepatocyte | 11 | 2 | 7 | 14 | |
| 952 | Mononeuropathy | NEURO000027 | 1.83 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 953 | CDH17/GALNT3 ratio | PRORT000548 | 1.83 | Protein ratios | Neural / glial | 1 | 1 | 8 | 8 | |
| 954 | CD40/TIMP3 ratio | PRORT000446 | 1.83 | Protein ratios | Vascular | 9 | 1 | 4 | 7 | |
| 955 | SPESP1 levels | PROLV001926 | 1.83 | Protein levels | Lymphocyte | 3 | 3 | 11 | 18 | |
| 956 | DARS1/MAP4K5 ratio | PRORT000859 | 1.83 | Protein ratios | Muscle / cardiac | 6 | 5 | 14 | 19 | |
| 957 | ABHD14B levels | PROLV000005 | 1.82 | Protein levels | Myeloid | 12 | 3 | 5 | 17 | |
| 958 | ATXN10/CASP10 ratio | PRORT000161 | 1.80 | Protein ratios | Granulosa cell | 1 | 4 | 9 | 24 | |
| 959 | F9/FURIN ratio | PRORT001091 | 1.80 | Protein ratios | Myeloid | 3 | 2 | 10 | 13 | |
| 960 | CSF1/IL10RB ratio | PRORT000777 | 1.80 | Protein ratios | Myeloid | 1 | 1 | 4 | 10 | |
| 961 | MAP4K5 levels | PROLV001269 | 1.80 | Protein levels | Stromal / connective | 21 | 3 | 9 | 10 | |
| 962 | NT5C3A levels | PROLV001440 | 1.80 | Protein levels | Stromal / connective | 13 | 6 | 11 | 20 | |
| 963 | RARRES2 levels | PROLV001706 | 1.80 | Protein levels | Myeloid | 81 | 3 | 7 | 10 | |
| 964 | ACHE levels | PROLV000012 | 1.80 | Protein levels | Hepatocyte | 125 | 2 | 8 | 15 | |
| 965 | ATOX1/SNAP29 ratio | PRORT000151 | 1.79 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 24 | |
| 966 | KL levels | PROLV001147 | 1.79 | Protein levels | Neural / glial | 1 | 1 | 3 | 12 | |
| 967 | GPKOW levels | PROLV000925 | 1.79 | Protein levels | Muscle / cardiac | 5 | 4 | 5 | 17 | |
| 968 | Hand grip strength | MSKEL000030 | 1.79 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 969 | SORT1/ST6GAL1 ratio | PRORT001803 | 1.77 | Protein ratios | B / plasma cell | 24 | 5 | 11 | 22 | |
| 970 | Respiratory infection | IMMUN000070 | 1.77 | Immunologic | Lymphocyte | 29 | 2 | 14 | 22 | |
| 971 | ARHGAP1 levels | PROLV000135 | 1.77 | Protein levels | Myeloid | 5 | 1 | 8 | 12 | |
| 972 | Infertility | REPRO000010 | 1.76 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 973 | CLIP2/LAT2 ratio | PRORT000666 | 1.76 | Protein ratios | Epithelial | 1 | 2 | 10 | 11 | |
| 974 | ADD1 levels | PROLV000039 | 1.76 | Protein levels | Lymphocyte | 1 | 1 | 9 | 31 | |
| 975 | LMNB2 levels | PROLV001218 | 1.76 | Protein levels | Myeloid | 6 | 1 | 14 | 18 | |
| 976 | STC1 levels | PROLV001960 | 1.75 | Protein levels | Vascular | 2 | 1 | 6 | 12 | |
| 977 | CD84/GP1BA ratio | PRORT000524 | 1.75 | Protein ratios | Vascular | 17 | 2 | 10 | 19 | |
| 978 | C4 levels | PROLV000233 | 1.75 | Protein levels | Vascular | 4 | 0 | 3 | 8 | |
| 979 | Granulocyte | HEMAT000031 | 1.74 | Hematologic | Myeloid | 770 | 2 | 8 | 12 | |
| 980 | RRAS levels | PROLV001755 | 1.74 | Protein levels | Lymphocyte | 9 | 2 | 6 | 14 | |
| 981 | MASP1 levels | PROLV001276 | 1.74 | Protein levels | Hepatocyte | 99 | 1 | 7 | 7 | |
| 982 | SH3BP1 levels | PROLV001853 | 1.74 | Protein levels | Myeloid | 33 | 1 | 7 | 6 | |
| 983 | Aortic elasticity | VASCU000049 | 1.73 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 984 | RGS18 levels | PROLV001731 | 1.73 | Protein levels | Myeloid | 1 | 3 | 8 | 14 | |
| 985 | PROK2 levels | PROLV001639 | 1.73 | Protein levels | Hepatocyte | 4 | 4 | 9 | 11 | |
| 986 | MPI levels | PROLV001334 | 1.73 | Protein levels | Stromal / connective | 10 | 5 | 10 | 15 | |
| 987 | Immune cell marker, Monocyte | HEMAT000027 | 1.73 | Hematologic | Myeloid | 15 | 2 | 9 | 12 | |
| 988 | ALKBH3 levels | PROLV000080 | 1.73 | Protein levels | Myeloid | 0 | 4 | 14 | 18 | |
| 989 | Ventricular mass | CARDI000012 | 1.73 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 990 | PPP1R14A levels | PROLV001614 | 1.72 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 991 | CEACAM8/VNN2 ratio | PRORT000590 | 1.72 | Protein ratios | Myeloid | 39 | 2 | 8 | 13 | |
| 992 | IGFBP3 levels | PROLV001030 | 1.72 | Protein levels | Hepatocyte | 67 | 2 | 10 | 17 | |
| 993 | SEPTIN8 levels | PROLV001814 | 1.72 | Protein levels | B / plasma cell | 0 | 2 | 8 | 24 | |
| 994 | AK2 levels | PROLV000071 | 1.71 | Protein levels | Myeloid | 13 | 2 | 5 | 16 | |
| 995 | FXYD5 levels | PROLV000841 | 1.71 | Protein levels | Myeloid | 24 | 4 | 11 | 19 | |
| 996 | IRAG2/TBC1D23 ratio | PRORT001367 | 1.70 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 19 | |
| 997 | OGA levels | PROLV001463 | 1.70 | Protein levels | Lymphocyte | 7 | 5 | 11 | 29 | |
| 998 | HNRNPK/VASH1 ratio | PRORT001294 | 1.70 | Protein ratios | Myeloid | 1 | 1 | 6 | 9 | |
| 999 | TANK levels | PROLV001992 | 1.69 | Protein levels | Stromal / connective | 1 | 5 | 12 | 33 | |
| 1000 | PODXL levels | PROLV001595 | 1.68 | Protein levels | Vascular | 18 | 1 | 5 | 12 |